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Summary 
The brain relies on the continuous supply of energetic substrates through the 
vascular system. Upon increased neuronal activity, the increase in cerebral blood flow 
(CBF) is commensurate to a raise in energy needs. This highly regulated link is termed 
as neurovascular coupling (NVC). CBF modulation occurs at the neurovascular unit 
(NVU) by means of an orchestrated interplay between neurons, astrocytes and micro-
vessels. Yet, the basic cellular mechanisms which underlie this stimulus-dependent 
CBF increase in NVC have not been fully elucidated and research in this field is 
currently on-going. Furthermore, NVC is disrupted in pathological conditions associated 
with cerebrovascular dysfunction such as stroke or Alzheimer’s disease. 
The experimental work described in this thesis aimed to investigate basic 
mechanisms of NVC in physiological conditions and NVC impairment in the presence of 
hypertension. 
In the first part of the thesis I investigated if the pathway activated by the 
metabotropic glutamate receptor mGluR5 is directly involved in the hemodynamic 
response initiation in the rat somatosensory cortex. Recently, a comprehensive model 
has been proposed in which astrocytes are activated by glutamate through mGluR5, 
with a subsequent spread of intracellular Ca2+ transients and activation of 
phospholipase A2. Phospholipase A2, in turn, activates a variety of pathways that 
ultimately lead to the astrocytic release of several vasoactive agents. Using concurrent 
optical imaging and determination of receptor occupancy with radiolabelled 11C-
ABP688, we report that blocking up to 80% of mGluR5 in vivo does not impair 
hemodynamic responses upon brief whisker stimulations while transiently reducing 
neuronal activity as measured by voltage-sensitive dye imaging. The reported data 
challenge the model outlining the astrocytes as first responders and principal mediators 
of functional hyperemia in vivo. Furthermore, our data are consistent with other in vivo 
experimental results, demonstrating astrocytic Ca2+ waves to be delayed in comparison 
to the vasodilation onset upon stimulation. 
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In a second study, NVC mechanisms were investigated in Spontaneous 
Hypertensive Rats (SHR), a well-established animal model of arterial hypertension. We 
studied CBF and hemodynamic responses upon whisker stimulation in SHR of different 
ages (10-20 and 40 weeks) and in age-matched Wystar Kyoto rats (CTRL). We applied 
a multimodal imaging approach using multiwavelength spectroscopy, laser speckle 
imaging, and two-photon microscopy. Compared to controls, increased arterial blood 
pressure in SHRs was associated with a progressive impairment in functional 
hyperemia in 20 and 40 weeks old SHRs. Baseline capillary red blood cell velocity 
(RBC) was higher in 40 weeks SHRs compared to CTRLs. Ten weeks treatment with 
verapamil or losartan did not reverse the hemodynamic impairment in 40 weeks old 
SHR but restored the RBC velocity measured in the resting condition. Impaired 
neurovascular coupling in SHR occurs only after a sustained period of increased blood 
pressure. Hence, monotherapy with verapamil or losartan is not sufficient to abolish this 
functional impairment. 
This thesis contributes to a better understanding of the basic mechanisms 
underlying NVC in physiological condition. Furthermore, it sheds light on the alteration 
of functional hyperemia in hypertension, one of the factors that may underlie the 
cerebrovascular component of important cognitive disorders.  
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Zusammenfassung 
Die kontinuierliche Energieversorgung des Gehirns wird über ein weit verzweigtes 
Gefässsystem und einen fein regulierten Blutfluss gewährleistet. Bei einer Zunahme der 
neuronalen Aktivität kommt es zu einer schnellen lokalen Steigerung des zerebralen 
Blutflusses, um den erhöhten Sauerstoffbedarf des aktiven Nervengewebes zu decken. 
Dieses orchestrierte Zusammenspiel zwischen neuronaler Aktivität und 
Hirndurchblutung wird neurovaskuläre Kopplung (NVK) genannt und basiert auf der 
Interaktion zwischen Astrozyten, Neuronen und Gefässwand (glatte Muskelzellen und 
Endothelzellen). Obwohl die NVK bereits vor mehr als 100 Jahren zum ersten Mal 
beschrieben wurde, sind viele der ihr zugrunde liegenden molekularen Mechanismen 
nicht vollständig geklärt. Gegenwärtig wird dieses Gebiet intensiv erforscht, um die 
Mechanismen besser zu verstehen. Hinzu kommt, dass die NVK bei vielen  
pathologischen Zuständen gestört ist, z. B. bei einem Schlaganfall oder degenerativen 
Hirnerkrankungen, wie der Alzheimer-Krankheit. 
In dieser Doktorarbeit wurden zwei grundsätzliche Fragestellungen bearbeitet:  
1. Welche Rolle spielt die Aktivierung des metabotropen Glutamatrezeptors 
mGluR5 für die NVK? 
2. Führt die arterielle Hypertonie zu einer Störung der NVK? 
 
In einer ersten Studie wurde untersucht, ob die Aktivierung des metabotropen mGluR5-
Glutamat-Rezeptors für die Einleitung einer hämodynamischen Reaktion grundlegend 
ist. Kürzlich wurde ein umfassendes Modell veröffentlicht, welches postuliert, dass 
durch neuronaler Aktivität freigesetztes Glutamat astrozytäre mGluR5 aktiviert. Diese 
Aktivierung setzt eine Kaskade von Prozessen in Gang, welche zu einer Erhöhung und 
intrazellulären Ausbreitung von Ca2+ und nachfolgender  Phospholipase A2-Aktivierung 
führt. Die Phospholipase A2 wiederum löst eine Vielzahl von Reaktionen aus, die 
letztendlich zur Produktion und Freisetzung verschiedener vasoaktiver Substanzen aus 
den Astrozyten führt. In der vorliegenden Arbeit wurden mittels multimodaler Bildgebung 
hämodynamische Signale, neuronale Aktivität und die mGluR5 - Rezeptorbelegung 
gemessen. Es konnte gezeigt werden, dass eine 80%-ige Blockierung des mGluR5 die 
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hämodynamische Antwort im somatosensorischen Kortex bei kurzer Stimulation der 
Schnurrhaare in vivo nicht beeinträchtigt. Hingegen wurde mittels 
spannungsabhängigen Farbstoffen eine transiente Verringerung der neuronalen 
Aktivität beobachtet. Diese Ergebnisse stellen das zuvor postulierte Modell in Frage, 
welches die Astrozyten als ″first responders″ und Hauptmediatoren der funktionellen 
Hyperämie beschreibt.   
Im zweiten Teil dieser Arbeit untersuchte ich den Einfluss von erhöhtem Blutdruck 
auf die NVK-Mechanismen bei spontan hypertensiven Ratten (SHR), einem gut 
etablierten Tiermodell für arterielle Hypertonie. Dazu wurden verschiedene 
hämodynamische Parameter sowie die Blutflussantwort auf sensorische Stimulation im 
somatosensorischen Kortex bei spontan hypertensiven Ratten unterschiedlichen Alters 
(10, 20 und 40-Wochen) gemessen und mit entsprechenden Kontrolltieren verglichen. 
Dazu wurde eine breite Palette von Imaging-Methoden eingesetzt: ″multiwavelength 
spectroscopy“, „laser speckle imaging“ und Zwei-Photonen Mikroskopie. Bei 20 und 40 
Wochen alten SHR ging die Zunahme des arteriellen Bluthochdrucks einher mit einer 
deutlichen Beeinträchtigung der funktionellen Hyperämie, bei 10 Wochen alten SHR 
wurde diese Veränderung der Hyperämie nicht beobachtet. Zusätzlich war die kapillare 
Ruhedurchblutung in 40 Wochen alten SHR erhöht. Interessanterweise konnte eine 10-
wöchige Monotherapie der SHR mit Antihypertensiva (Verapamil und Losartan) die 
Beeinträchtigung der sensorischen hämodynamischen Antwort bei 40 Wochen alten 
Tieren nicht rückgängig machen. Der Ruheblutfluss hingegen wurde so 
pharmakologisch normalisiert. Zusammenfassend kann gesagt werden, dass die 
Beeinträchtigung der neurovaskulären Kopplung bei arterieller Hypertonie erst nach 
einem länger andauernden  Zeitraum mit  erhöhten Blutdruckwerten eintritt. Ausserdem 
reicht eine Monotherapie mit Verapamil oder Losartan  nicht aus, um die funktionelle 
Einschränkung zu verbessern. 
Diese Arbeit hinterfragte die Rolle von astrozytären Calciumwellen für die NVK im 
gesunden Organismus. Im zweiten Teil wurde  der Einfluss einer systemischen 
hämodynamischen Störung (arterielle Hypertonie) auf die lokale zerebrale Perfusion 
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untersucht. Sie soll zu einem besseren Verständnis der zerebralen Blutflussantwort 
sowohl in physiologischen als auch pathologischen Situationen beitragen. 
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Chapter 1. Introduction  
Neurovascular coupling: a historical perspective 
The human brain has a high energy demand. Although it constitutes only 2% of the 
body weight, it is responsible for approximately 25% of total body glucose utilization and 
20% of total oxygen consumption. Given the brain has limited capacity for energy 
storage, it is heavily dependent upon the continuous blood supply of energetic 
substrates (Sokoloff 1960). All brain functions require adequate supply of oxygen and 
glucose, which are provided through the blood circulation with tight spatiotemporal 
control. An inadequate supply of energetic substrates leads to neuronal and glial 
damage, and ultimately cell death. These phenomena have been reported in some 
pathological conditions such as ischemic stroke and vasospasm following sub-
arachnoid hemorrhage (Attwell et al. 2010). In physiological conditions, astrocytes, 
neurons, microvessels and pericytes tightly interact to induce a rapid and localized 
increase in cerebral blood flow (CBF), providing the sufficient energy supply to active 
cells. This process is defined as neurovascular coupling (NVC). 
The first observations of NVC were performed more than a century ago by the 
eminent Italian physiologist Angelo Mosso (Mosso 1881). He performed measurements 
in patients with skull defects. In particular, Michele Bertini, a 37 year old male, reported 
a round defect of about 20 mm diameter in his right frontal skull after an accident. This 
defect represented a suitable brain window to attach Mosso’s apparatus containing a 
sensitive pressure transducer. He continuously measured pulsations and volume 
changes from the brain window and from the forearm in parallel. This was done in order 
to separate local brain processes from systemic responses to a task. When either the 
subject was asked to make a simple calculation or when he reported the result, cerebral 
blood volume and pulse height increased, whereas the systemic measurements from 
the forearm were unchanged (Figure 1). Mosso observed for the first time blood flow 
pulsations variations during certain cognitive events. According to Mosso’s notes, this 
key experiment was performed on September 23rd, 1878, and since then, innumerable 
experiments have confirmed this initial observation (Raichle and Mintun 2006a). In 
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1890, the seminal work On the regulation of the blood-supply of the brain was published 
by the British scientists Charles Roy and Charles Sherrington (Roy and Sherrington 
1890). By means of oncographic measurements from the parietal cortex of anesthetized 
dogs, localized increases in blood flow were shown to be coupled to specific stimulation 
of sensory nerves. Their experimental approach allowed them to extend Mosso’s 
conclusions about regional variations of blood flow corresponding to localized changes 
in brain activity. One of their key findings was: 
“Bearing in mind that strong evidence exists of localization of function in the 
brain, we are of opinion that an automatic mechanism … is well fitted to provide 
for a local variation of the blood-supply in accordance with local variations of the 
functional activity”.  
These first experimental observations outlined basic concepts in the NVC field that 
are still the object of investigation today. 
Roy and Sherrington also used pharmacological manipulations to assess the 
importance of vasoactive agents in the initiation and control of NVC. They reported (Roy 
and Sherrington 1890):  
“The blood supply of any part of the cerebral tissue is varied in accordance 
with the activity of the chemical changes which underlie the functional action of 
that part”. 
Since these first pioneering studies, CBF changes evoked by neuronal activity have 
been extensively used to explore brain function.  
 Chapter 1. Introduction 
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Figure 1. A first open window to investigate neurovascular coupling; Angelo Mosso’s experiment in the 
1880s. 
On the left, drawing of the instrument used to detect cerebral blood pulsations and volume changes from the cranial 
window of the patient Michele Bertini. On the top right, the instrument used to measure the pressure variations at the 
forearm is shown. On the bottom right, example traces recorded before and after a calculation task (indicated with 
α=8x12). Note the increase of cerebral blood pulsations (upper tracer) after the task whereas no change at the 
forearm level was reported, representing the systemic situation (bottom trace). 
 
In the last century, important progress was made in the field of human brain imaging 
through the development of new techniques relying on the tight coupling between local 
neuronal activity increase and subsequent changes in CBF. These brain imaging 
techniques continue to be refined. One of the most commonly used techniques in basic 
research is functional magnetic resonance imaging (fMRI). When brain tissue is 
activated, the fMRI Blood-Oxygenation-Level-Dependent (BOLD) signal increases in 
response to a decreased amount of deoxyhemoglobin (HbR) in a given region, and is 
used as a surrogate for neuronal activity. 
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However, despite significant progress in neuro-imaging, the basic mechanisms 
underlying the relationship between neuronal activity and CBF are not yet fully 
elucidated. A better understanding of NVC is essential to properly interpret functional 
imaging data, now routinely used in patients, and may contribute to the development of 
new treatments for central nervous system (CNS) disorders. 
The vascular organization of the brain and the neurovascular unit 
The human brain continuously receives blood at the rate of approximately one liter 
per minute through two arterial roots: the vertebral arteries and internal carotid arteries. 
The vertebral arteries band together into the basal artery that, together with the carotid 
and the posterior communicating arteries, creates a vascular circle at the base of the 
human brain, known as the circle of Willis, and named after Sir Thomas Willis who 
described the arterial circle (circulus arteriosus cerebri) (Purves et al. 2004). This 
structure surrounds the base of the hypothalamus and pituitary gland stalk. Due to the 
numerous anastomoses, it essentially creates 
redundancy in the vascular system because of 
the ability to preserve cerebral perfusion to the 
brain. This occurs even if one of the main 
input arteries supplying the circle becomes 
occluded. There are numerous anastomoses 
within the pial network, but within the cerebral 
cortex, there is a significant reduction in 
anastomoses between arteries as well as 
arterioles.  
Figure 2. Diagram of the arterial circulation at the base of 
the brain.  
Reproduction of a lithograph plate from Gray’s Anatomy of the 
human body (1918). 
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As a consequence, even a small arteriolar occlusion can rapidly lead to oxygen 
deprivation and cause stroke. 
For our research, rats were employed as a laboratory animal model. Although the 
gross anatomical organization of the cerebro-vascular system is largely similar between 
humans and rats, there are some important differences. These are: (i) the anterior 
communicating artery is present in humans but not in rats, and (ii) the olfactory artery is 
present only in rats (Lee 1995). 
Large cerebral arteries divide progressively into smaller arteries that run along the 
surface of the brain, named pial arteries (Figure 3). Pial arteries penetrate deeper into 
the brain, oriented 
perpendicular to the surface 
(cortical arteries). These 
give rise to cerebral 
parenchymal arterioles and 
eventually to capillaries, 
forming the capillary bed 
(Jones 1970). The Virchow-
Robin, a perivascular funnel-
shaped space, is the 
continuation of the 
subarachnoid space, 
surrounding pial arteries, 
veins and penetrating 
arterioles. It separates the 
vessels from the brain 
parenchyma (Weber et al. 2008; Zhang et al. 1990).  
Figure 3. The neurovascular Unit. 
Pial arteries penetrate perpendicular to the cortical surface (as so-called cortical arteries) and then divide into 
intracerebral arterioles and capillaries. SMCs modulate the vessel diameter of arteries and arterioles but are absent 
in capillaries. At the capillary level, astrocytic endfeet enwrap the vessel wall together with pericytes and perivascular 
neurons. From Iadecola C. "Neurovascular regulation in the normal brain and in Alzheimer's disease." Nature 
Reviews Neuroscience, (Iadecola 2004). 
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As soon as the Virchow-Robin space disappears, parenchymal arterioles and 
capillaries run within the neuropil, in direct contact with neuronal processes and 
astrocytic endfeet (Figure 3). At the capillary network level, a tight exchange of 
energetic substrates and oxygen between tissue and blood occurs.  
 
The capillary bed consists of a dense network of intercommunicating vessels, that 
totals 400 miles in length in the human brain (Zlokovic 2005), and at this level the 
exchange of oxygen and nutrients occur. It has been estimated that each neuron has its 
own capillary, further confirming the importance of the link between vascular 
compartment and neurons (Cipolla 2009). The venous system ensures that the blood is 
drained from the capillary bed up to the surface of the brain by ascending vessels, 
which converge into sinuses. 
Generally, the wall of cerebral arteries and arterioles is comprised, from the innermost 
to the outermost layer, of; the tunica intima, with a layer of endothelial cells and the 
internal elastic lamina, the tunica media consisting of smooth muscle cells (SMC), and 
the tunica adventitia, made up of collagen fibers, perivascular nerves and connective 
tissue. However, between the different vessel types some structural variations in the 
vessel architecture can be detected. Firstly, perivascular nerves are entwined around 
the outermost layer of pial arteries (extrinsic innervation) whereas pericytes and 
astrocytes enwrap the smallest arteries such as arterioles and capillaries. Secondly, the 
number of SMC layers varies with the size of the vessels, from two to three for pial 
arteries to only one for arterioles and none in capillaries. Despite these differences, all 
cerebral vessels have endothelial cells which are sealed by tight junctions and form, 
together with the basal lamina and pericytes, the Brain Blood Barrier (BBB). The BBB is 
a physical barrier capable of ensuring neuronal homeostasis and achieves this via 
strictly regulating the exchange of solutes, water, and nutrients between the blood and 
the brain (Zlokovic 2008). 
The endothelium is supported by the basement membrane and enwrapped by 
pericytes, astrocytic endfeet and neuronal synapses. Together this constitutes a 
functional unit, denoted as the neurovascular unit (NVU). Dynamic communication 
between the cells of the NVU controls different functions such as CBF increase after a 
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specific stimulation, BBB permeability and homeostatic maintenance during stress 
response.  
Pericytes surround almost all capillaries, small arterioles and venules, sending 
processes around and along the capillaries. More specifically, they are separated from 
the endothelial cells layer and the parenchyma by a basal lamina layer. In addition to 
being part of the NVU, pericytes support several functions such as angiogenesis, vessel 
stabilization and endothelial cell regulation. Furthermore, anatomical and morphological 
evidence (e.g. pericytes surround capillaries which lack SMC) suggests that pericytes 
might have an active role in CBF regulation via capillary lumen modulation, but this topic 
is highly debated (Hamilton et al. 2010).  
Astrocytic endfeet not only partially surround the vessel walls but constitute a 
complete covering of the brain microvessel walls. The endfeet interdigitate and overlap 
without leaving slits between them, as observed by electron microscopy 3D 
reconstruction in the rat hippocampus (Mathiisen et al. 2010). 
Following from the above, it is clear, why research in the NVC field has focused 
primarily on the complex cross-talk between all cell types of the NVU. Following 
anatomical description of NVU members, their functional contribution to blood flow 
regulation is described in the “Functional Hyperemia” chapter. 
Much of the morphological knowledge of cerebral microvasculature has come from 
electron microscopy studies of vascular corrosion casts and histochemistry (Weber et 
al. 2008). In short, Weber et al. (2008) have quantified the vasculature in the macaque 
visual cortex and report that: (i) vascular density is much higher in gray than in white 
matter and is highest in layer IV; and (ii) that the relationship between vascular and 
neuronal density is weak but with a strong correlation between patterns of oxidative 
metabolism and microvascular density. More recently, two-photon laser scanning 
microscopy (2PLSM) has been employed to specifically study three-dimensional 
microvascular topology (Tsai et al. 2009). 2PLSM technology has been utilized also by 
our group and is further outlined in Chapter 3. In these 2PLSM experiments, the plasma 
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was labeled with a fluorescent dextran enabling subsequent imaging of the vasculature 
and the determination of vascular density and vessel lumen diameter in the cortex.  
Brain metabolism 
Until relatively recently, blood-borne glucose was considered the unique energy 
substrate supporting neuronal activity in the healthy brain (Sokoloff 1989). Glucose is 
transported from blood across the BBB and enters the brain via specific glucose 
transporters (Vannucci et al. 1997). Glucose Transporter 1 (GLUT1) is primarily found 
on endothelial cells and glia and GLUT3 is found on neurons. After entering the brain 
cell, glucose is metabolized to CO2 and water. This occurs via: i) glycolysis, providing 2 
mol of adenosine triphosphate (ATP) per mol of glucose; and ii) the tricarboxylic acid 
(TCA) cycle, providing 30 mol of ATP/mol of glucose. 
In 1986, Fox and Raichle used Positron Emission Tomography (PET) to show that 
activity-dependent increases in CBF and glucose consumption outstrip the concomitant 
changes in oxygen consumption (Fox and Raichle 1986). Indeed, they challenged the 
assumption that the majority of energy used by active neurons comes from oxidative 
phosphorylation rather than glycolysis as the predominant energy source during 
neuronal activity. The reported mismatch between CBF increase and oxygen 
consumption causes a restricted hyperoxygenation with decreased HbR which provides 
the basis for the BOLD signal used by the functional MRI. 
In the mid-1990s, Pellerin and Magistretti (1994) observed a stimulation of glucose 
uptake into astrocytes and subsequent predominant metabolism to lactate. Starting from 
this experimental evidence, the astrocyte-neuron-lactate shuttle hypothesis (ANLSH) 
was proposed. According to the ANLSH, the glutamate released from neurons during 
activation is taken up by astrocytes, leading to an activation of the astrocytic Na+-K+ 
ATPase, which in turn consumes ATP. The reduction in ATP levels stimulates astrocytic 
glycolysis leading to lactate production. Lactate produced by astrocytes is released to 
the extracellular space and taken up by neurons to fuel their energetic needs. 
Furthermore, several reports demonstrated that lactate may constitute the preferred 
energy substrate for neurons over glucose (Hyder et al. 2006; Jolivet et al. 2009; Wyss 
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et al. 2010). In addition, various important roles have been attributed to lactate recently. 
For example, it was shown that lactate released from astrocytes modulates the activity 
of neighboring GABAergic neurons in the subfornical organ (SFO) (Shimizu et al. 2007) 
and that lactate dictates the vascular response by controlling the vessel diameter 
(Gordon et al., 2008). Finally, the flow of extracellular lactate through pericytes was 
shown to directly control the contractile force exerted on retinal capillaries (Yamanishi et 
al. 2006). These results suggest that lactate could be at the center of metabolic 
regulation of brain activity affecting both local blood flow and the energy state of 
neurons and thus the activity of the local network. 
Functional hyperemia 
When brain regions are activated by a specific stimulus, CBF increases in the 
corresponding area. This close coordination between neuronal activity and CBF is 
denoted as functional hyperemia. To allow CBF increase in a defined area, members of 
the NVU act in concert to elicit vasodilation at the capillary level, and to regulate the 
maintenance and termination of the functional hyperemic response. The first 
hemodynamic response is initiated in the parenchyma, and shortly after (200 ms) 
spreads to the surface arterioles supplying the activated area (Chen et al. 2010). The 
blood flow increase is associated with a reduction of vascular resistance that, in arteries 
and arterioles, is controlled by SMCs.  
SMCs are also capable of maintaining constant CBF within a certain blood pressure 
range (60-150 mm Hg). This process is known as cerebrovascular autoregulation. 
SMCs contract when the intravascular pressure increases and constrict in response to 
reduced pressure (Bayliss 1902). The myogenic response is initiated by an increase in 
blood pressure which depolarizes the SMC membrane and triggers calcium influx via 
voltage-gated ion channels. Higher intracellular calcium concentration increases myosin 
light chain phosphorylation and induces vasoconstriction (Brayden et al. 2008). 
However, SMC vasodilation could be due to hyperpolarization through K+ channel 
activation and reduced phosphorylation of myosin light chain upon PGE2 release 
(Attwell et al. 2010).  
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Major hypotheses: metabolic and neurogenic hypotheses 
To date, an unanswered question has been: why and how does CBF change with 
the changes in brain activity? This question has attracted the attention of many 
scientists in the NVC field during the last century. In examining the literature produced 
from these investigations, two main theories have arisen attempting to explain the link 
between CBF and neuronal activity. According to the traditional metabolic hypothesis, 
CBF increases in order to compensate for the increased need of glucose and oxygen in 
activated neurons (Raichle and Mintun 2006b). In other words via a negative feedback 
system, a localized decrease of energetic substrates (Oxygen (O2) or glucose) or the 
production of carbon dioxide (CO2) elicits a compensatory CBF increase. This paradigm 
may represent an oversimplification of a more complex process. Indeed, the negative 
feedback mechanism theory is unable to explain compelling evidence such as: (i) blood 
oxygenation and CBF decrease occur concurrently with an increase in glucose uptake 
and neuronal activity (Devor et al. 2008); and (ii) stimulus-evoked CBF increases have 
been recorded also in the absence of deoxygenated hemoglobin (Lindauer et al. 2010). 
Alternatively, the more recent neurogenic hypothesis has been proposed to explain 
increased CBF via a feed-forward mechanism. This proposes either active neurons or 
astrocytes release vasoactive agents into the vessels, eliciting a vascular response 
without involving metabolic substrates (Attwell et al. 2010) (Figure 4). 
 
Figure 4. Metabolic and neurogenic hypotheses.  
Adapted from Attwell et al. 2010. 
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Neuronal control of CBF 
Current evidence suggests that neurons and astrocytes are both important 
contributors in the signaling process that links vascular responses to changes in 
neuronal activity. Focusing first on neurons, hemodynamic responses in the 
somatosensory cortex have been shown to correlate with local field potentials, 
indicating that vascular changes are directly linked to incoming neuronal inputs in a 
specific area (Logothetis et al. 2001). 
Here, I briefly describe the perivascular innervations, for a better understanding of 
the neuronal contribution to cerebrovascular tone. 
Extrinsic innervations. Pial arteries and arterioles on the brain surface contain 
perivascular nerves that originate in the peripheral nervous system (PNS). More 
specifically, the extrinsic innervation has its origin from different ganglia (Hamel 2006):  
(i) The superior cervical ganglion (SCG), from where sympathetic innervations 
arise releasing neuropeptide Y (NPY) and norepinephrine (NE), both 
vasoconstrictors;  
(ii) The sphenopalatine (SPG) and otic (OG) ganglia, from where 
parasympathetic nerves originate releasing vasoactive intestinal peptide 
(VIP), acetylcholine (ACh) and nitric oxide (NO); and 
(iii) The trigeminal ganglion (TG), starting point for sensory nerves containing 
substance P (SP) and calcitonin gene related peptide (CGRP), both 
vasodilators. 
Intrinsic innervations. Parenchymal arterioles and cortical microvessels are 
innervated from neurons that originate in the CNS. The main vasoactive pathways arise 
from:  
(i) Nucleus basalis with cholinergic projections; 
(ii) Raphe nucleus with serotoninergic projections; and 
(iii) Locus coeruleus with noradrenergic fibers.  
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Activation of cholinergic fibers from the basal forebrain (BF) induces significant 
increases in cortical perfusion together with a dilation of intracortical microvessels 
(Lecrux et al. 2012). The NVC response following BF stimulation is mediated by 
glutamate from pyramidal neurons, by EETs, likely released by astrocytes, and possibly 
by GABA from specific subsets of interneurons. Following stimulation of the locus 
coeruleus, the observed CBF decrease has been described to be mediated by 
astrocytes, whereas bidirectional changes in vascular tone have been reported upon 
raphe nucleus activation (Cohen et al. 1996). 
An additional neuronal pathway for the modulation of cortical blood flow occurs via 
the rostral ventrolateral medulla, whose projections to the cortex are relayed by the 
interlaminar thalamic nucleus (Golanov and Reis 1996). 
Furthermore, other important local pathways involve local inhibitory and excitatory 
neurons that integrate the signal within the NVU.  
GABA interneurons. Inhibitory GABA interneurons have been described to act as 
“local integrators” of NVC for subcortical regions (Cauli et al. 2004), able to convert 
neuronal signals into vascular responses. They are indeed positioned in close contact 
with pyramidal cells and project to neighboring microvessels and astrocytic endfeet. 
Different GABA interneurons release vasodilating transmitters such as NO (see 
below) and vasoactive intestinal peptide (VIP) or vasoconstricting factors, such as the 
neuropeptide somatostatin (SOM), and NPY (Lecrux and Hamel 2011) (vasoactive 
molecules collected in the summary table 1). Evidence for the active role of GABA 
interneurons in NVC was first provided by in vitro experiments in brain slices (Cauli et 
al. 2004). More recently and tellingly, in vivo studies (Kocharyan et al. 2008; Lecrux et 
al. 2011) have suggested that specific GABA interneurons are employed according to 
the nature of the stimulus. In this connection, GABA interneurons expressing VIP or 
choline acetyltransferase (ChAT) shape the hemodynamic responses to whisker 
stimulation via GABA-A mediated synchronization of the cortical network (Lecrux et al. 
2011).  
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Excitatory pyramidal neurons. Glutamate is the primary excitatory 
neurotransmitter in the CNS (Attwell and Laughlin 2001), activating ionotropic receptors 
(N-methyl-D-aspartate (NMDA), α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
(AMPA), and kainate receptors) and mGluR. Thalamocortical glutamatergic afferent 
fibers release glutamate at the barrel cortex level and recruit excitatory pyramidal 
neurons through NMDA activation. This leads to: (i) calcium entry into neurons, nNOS 
activation and release of the vasodilating NO; (ii) glutamate release which can also 
directly interact with astrocytes; and (iii) release of prostanoids, the dilatory 
cyclooxygenase-2 (COX2) derived products (Lecrux et al. 2011). 
Figure 5. Scheme of the different perivascular nerves.  
Extrinsic nerves originate from the peripheral nervous system (superior cervical, sphenopalatine, otic or trigeminal 
ganglion). Intrinsic nerves from CNS innervate arterioles within the parenchyma. Cortical microvessels receive NA, 5-
HT, ACh, or GABAergic afferents from neurons from the locus coeruleus, raphe nucleus, basal forebrain, or local 
cortical interneurons. From Hamel, E. "Perivascular nerves and the regulation of cerebrovascular tone." J Appl 
Physiol.(2006). 
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Nitric Oxide. NO is also an important vasoactive molecule released from neurons. 
NO is produced by neuronal NO synthase (nNOS) upon NMDA receptor activation and 
diffuses to vascular SMC where vasodilation is induced by guanylate cyclase 
stimulation. It has been shown that NO acts as a permissive factor or modulator, rather 
than a main signaling factor. This is because NO donors can restore completely the 
attenuation of evoked CBF signals due to nNOS inhibition (Lindauer et al. 1999). 
Astrocytes as intermediaries of the neurovascular coupling response  
For a long time astrocytes were regarded to be only supportive cells. However, over 
the last 20 years this view has changed. Accumulating data has corroborated the view 
that astrocytes act as active partners in the so called “tripartite synapse,”(Perea et al. 
2009) and in serving as bridges between active neurons and capillaries (Attwell et al. 
2010). From a morphological point of view, astrocytes are in a strategically ideal 
position. On the one hand, they surround synaptic processes and with their endfeet 
enwrap blood vessels. Moreover, the processes from a single rodent astrocyte can 
sense the activity of about 90,000 synapses (Oberheim et al. 2006). Furthermore, each 
astrocytic domain has minimal overlap with neighboring astrocytic domains, creating 
glially-defined synaptic islands (Halassa et al. 2007). Additionally, by in vivo 2PLSM 
experiments, peaks of astrocytic laminar density have been shown to mirror the density 
of capillaries (at 40 µm and at 500 µm below the cortex), (McCaslin et al. 2010) and the 
neuronal density (peaking at 600 µm), (Tsai et al. 2009) in the mouse somatosensory 
cortex. This suggests strong physiological interactions between neurons, vessels and 
astrocytes. 
Regarding the role of astrocytes in NVC, Zonta and colleagues (2003) described in 
acute cortical slices, that arteriolar dilation evoked by electrical stimulation of neuronal 
afferents, depends on astrocytic calcium wave propagation. After blockade of mGluR5, 
the CBF response was impaired leading to the conclusion that activation of mGluRs is a 
key step in evoking astrocytic calcium waves. Furthermore, the authors showed that 
Ca2+ increases in glial cells elicited vasodilation mediated by COX production. However, 
other in vitro experiments have reported conflicting results: Mulligan and colleagues 
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(2004) observed vasoconstriction mediated by production of the ω-hydroxylase 
metabolite 20-HETE. Metea and Newman (2006) found that in isolated mammalian 
retina the different vasomotor responses can be modulated by NO. This plethora of in 
vitro data clearly pointed out the need for in vivo studies in which physiological vascular 
tone is maintained and in which all NVU elements are intact. In the highly cited in vivo 
study by Takano et al. (2006) vasodilation was observed to be associated with elevation 
of endfoot Ca2+ and reduced by a selective COX-1 inhibitor. This suggests that 
prostaglandin E2 (PGE2), a product of COX metabolism, is likely to be involved in CBF 
regulation. Interestingly, conflicting results have been reported regarding astrocytic 
activation via mGluR5 in the olfactory bulb. Whereas Petzold and colleagues could 
replicate a reduction in hemodynamic signal upon mGluR5 blocker application (Petzold 
et al. 2008), other researchers found the odor evoked signals were independent of 
ionotropic or metabotropic receptor activation but were affected by blockade of 
astrocytic glutamate transporter (Gurden et al. 2006). In chapter 3, our research data 
addressing this question are described.  
In addition to the activation of the arachidonic acid metabolites pathway, astrocytic 
Ca2+ increases can also induce potassium ion (K+) release through activation of large 
conductance Ca2+ sensitive K+ channels (BK), located on astrocytic endfeet. The K+ 
induces vasodilation in SMC by hyperpolarization via inward rectifier Kir channels (Filosa 
et al. 2006; Girouard et al. 2010). 
What determines whether arterioles dilate or constrict upon a high Ca2+ 
concentration in astrocytes? Gordon and colleagues (2008) have shown in acute 
hippocampal brain slices that the metabolic state of rat brain tissue altered by O2 
availability is the factor responsible for inducing either a vasodilation or vasoconstriction 
via indirectly modulating lactate production. Nevertheless, these results were not 
confirmed in a recent in vivo study (Lindauer et al. 2010), suggesting that changes in O2 
level in the cortex do not directly regulate NVC. The rat cortex was kept at high O2 
concentration by perfusion with hyperbaric oxygen, but the blood flow response to 
forepaw stimulation was not affected.  
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Overall, astrocytes appear undoubtedly to have an important role as intermediaries 
between neurons and blood vessels. However, further investigations are needed to 
answer many unresolved questions, for example: What is the temporal sequence in the 
recruitment of neurons and astrocytes? And, is activation of astrocytes triggered by 
specific neuronal cell population? 
CBF control at the capillary level: role of pericytes 
Pericytes have recently been a focus of interest in the neuroscience field due to their 
potentially important role in modulating vascular resistance at the capillary level. The 
anatomical features of pericytes have sustained research interest in the NVC field. 
Beyond their morphology and location, the number of pericytes in the brain is greater 
than in any other areas of the body, and they express contractile proteins (Hamilton et 
al. 2010).  
Pericytes have been shown to control the capillary diameter in retina and cerebellar 
brain slices via constriction of capillary diameter in response to NE stimulation and 
GABA receptor inhibition and via dilation of capillaries in response to glutamate 
(Peppiatt et al. 2006). Recently, in vivo studies have investigated pericyte’s role in the 
intact brain. Using transgenic mice expressing GFP in endothelial cells and pericytes, 
the capability of pericytes to contract capillaries in vivo has been shown by Fernandez-
Klett and colleagues (2010). In this study, pericytes induced a constrictive response to a 
thromboxane A2 analogue but did not show any induced dilation upon bicuculline 
application (GABA receptor antagonist). Dilation was only observed in precapillary 
arterioles, penetrating and pial arterioles, interestingly, indicating that relaxation of 
capillaries is not required for the development of a functional hyperemic response. 
Furthermore, the availability of adult viable pericyte-deficient mice allowed to study the 
effect of pericyte loss. Vascular damage was observed through: (i) reduction in brain 
microcirculation with consequent reduced CBF responses; and (ii) BBB breakdown (Bell 
et al. 2010). The importance of pericytes in disease has also been described; after 
ischemia, pericytes are involved in acute microcirculatory disturbance by contracting in 
response to oxidative-nitrative stress (Yemisci et al. 2009)  
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Concerning pericytes function in NVC, in vivo research is very recent. Further efforts 
are required to precisely define the importance of these unique cells in the complex 
blood flow regulation process both in physiological and pathological conditions (Yemisci 
et al. 2009). 
Table 1. Summary table of vasoactive molecules. 
Origin Effect on vessels Vasoactive molecule Mediator 
Neurons 
 
Vasodilating Nitric oxide (NO) NOS and NPY interneurons 
(Endothelial cells eNOS) 
Vasoactive intestinal peptide (VIP) VIP interneurons 
Prostaglandins (PG) and prostaglandin 
E2 (PGE2) 
COX2 pyramidal neurons 
Acetylcholine (Ach) Subcortical neurons 
Substance P Peripheral neurons 
γ-aminobutyric acid (GABA) Interneurons 
Adenosine  
Calcitonin gene-related peptide (CGRP) Peripheral neurons 
Vasoconstricting Somatostatin (SOM) Somatostatin neurons 
Serotonin (5-HT) Raphe nucleus neurons 
Noradrenalin (NA) Locus coeruleus neurons 
Dopamine Interneurons 
Neuropeptide Y (NPY)  
Astrocytes Vasodilating Prostaglandins (PG) and prostaglandin 
E2 (PGE2) 
COX1 
Epoxyeicosatrienoic acids (EETs) P450 epoxygenase 
Adenosine  
Vasoconstricting 20-HETE  
Vasoactive 
ions 
Vasodilating High Extracellular [K+]  
Decreased pH, > [H+]  
Vasoconstricting Increased pH, <[H+]  
Blood 
metabolites 
Vasodilating Lactate  
Vasoconstricting CO2  
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The whisker to barrel system 
Many nocturnal animals including rodents explore the surrounding environment 
using their whiskers to detect and spatially locate objects. This so-called whisking, is a 
backwards and forwards whisker motion used to acquire information from the 
environment and to identify objects, shapes and textures (Lubke and Feldmeyer 2007).  
Whiskers in the rat snout are organized in a grid with 5 different rows, named from A 
to E, and arcs, numbered from 1 to 5 or up to 9. Consequently, each whisker is uniquely 
denoted by the coordinates of a row and an arc, e.g C2. This layout of the whiskers is 
reproduced in all rat snouts. Each whisker is attached to the skin by a follicle, innervated 
by the peripheral branches of 200 cells of the trigeminal ganglion. At the follicle level, 
each whiskers mechanical movement is converted into an action potential of these 
nerve endings, bearing the sensory information from the whisker follicles to the brain 
stem nuclei. The trigeminal nuclei convey afferent vibrissal information to the thalamus 
via parallel pathways that then reach the barrel field of the somatosensory cortex. Every 
single whisker is strongly connected to a single barrelette at the brain stem level, to a 
barreloide at the thalamus, and to a single barrel at the somatosensory cortex. 
Barrelettes, barelloides, and barrels are arranged as a topographic projection of the 
whiskers themselves. There is a clear layout of the barrels at the somatosensory cortex 
that mirrors the whisker map on the rat’s snout (Diamond et al. 2008).  
Each barrel appears as a 300 µm diameter column that contains 10,000-20,000 
neurons, arranged in six layers. These neurons are primarily excitatory neurons 
providing most of the local, cortico-cortical, and extracortical projections, as well as 
inhibitory GABA interneurons (Lubke and Feldmeyer 2007). Additionally, the 
glutamatergic neurons form cortico-cortical synapses and reciprocally connect the 
primary somatosensory cortex to the secondary somatosensory corte and primary 
motor cortex on the same hemisphere. 
Given the glutamatergic pathway from the whisker to the barrel cortex has been so 
well described, the whisker to barrel system in rodents constitutes an ideal model to 
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explore NVC mechanisms. For this reason it has been extensively used since 
pioneering experiments in this field (Orbach et al. 1985).  
 
Figure 6. From whisker to barrel cortex: a system often used for NVC studies.  
The vibrissae of each side of the rat snout are organized in a grid, formed of 5 rows, each of these containing from 5 
to 9 whiskers. Nerve endings bring the information from each whisker to the brain stems, after that neurons project to 
the thalamic somatosensory nuclei and finally to the barrels of somatosensory cortex. From Diamond, M. E., M. von 
Heimendahl, et al. "'Where' and 'what' in the whisker sensorimotor system." Nat Rev Neurosci (2008).  
Neurovascular coupling in disease: the hypertension example 
The effect of hypertension (HT) on NVC is one of our research topics, and is 
reported in chapter 3. Here, I would like to briefly introduce the main research findings 
published to date relating to hypertension and NVC.  
HT is one of the most widespread health issues facing Western countries and is 
defined as an elevation of blood pressure above 140 mm Hg systolic or 90 mm Hg 
diastolic. HT has known deleterious effects on blood supply to the brain and is a strong 
risk factor for stroke and over time a significant cause of cognitive decline (Dahlof 
2007). 
From a structural point of view, HT may lead to numerous changes in cerebral 
arteries and arterioles (e.g. atherosclerosis, hypertrophic remodeling and vascular 
stiffening), resulting in vascular occlusions, alteration of the mechanical properties of the 
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vessels, and changes in the composition of the vessel wall. These structural changes 
have several functional implications. Whereas resting CBF has been reported to be 
unchanged or slightly reduced, functional hyperemia in HT is attenuated in several 
animal models and human studies. Overall, structural and functional changes in HT 
induce an impaired compensatory capacity of the cerebral circulation and increased 
brain susceptibility to vascular insufficiency (Iadecola and Davisson 2008). Furthermore, 
oxidative stress is considered a critical factor for HT’s cerebro-vascular effects. Reactive 
oxygen species (ROS) production, increased in cerebral vessels in a model of 
angiotensin II-induced hypertension, and, more specifically, peroxynitrite, the product of 
NO and the radical superoxide, constitutes one of the main pathways responsible for 
deleterious effects of HT (Girouard et al. 2007). 
Therefore, although the effect of HT on the brain has recently become an object of 
increased research interest, many open questions remain. For example, how much 
does blood pressure need to be reduced to prevent brain damage? What are the 
possible cognitive deficits? Also, which is the best anti-hypertensive treatment able, not 
only to reduce blood pressure, but also to protect brain circulation and function? Finally, 
how do HT and aging interact in the development of cerebro-vascular impairments?  
Optical imaging: state of the art 
In the last few decades, technological advancement has enabled a broad array of 
significant findings in the NVC field. Digital cameras and the advent of laser sources 
have provided new tools for a multifaceted approach to studying in vivo CBF regulation 
with previously unreached spatial and temporal resolution. Despite these 
advancements, numerous questions remain which may now begin to be answered with 
recently improved imaging tools. Here, I will focus on recent developments in optical 
microscopy technologies for in vivo studies on NVC and neurometabolism. Some of 
these developments are described in more detail in the methods section of chapter 3. 
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Figure 7. Comparison of optical images technologies.  
Comparison of spatial resolution, temporal resolution and penetration depth of neurovascular and neuro metabolic 
optical imaging techniques. From Devor, A., S. Sakadzic, et al. "Frontiers in optical imaging of cerebral blood flow and 
metabolism." J Cereb Blood Flow Metab. (2012). 
Vascular and hemodynamic imaging 
Hemoglobin concentration and oxygenation 
Optical intrinsic imaging. 25 years ago, Grinvald and colleagues introduced 
intrinsic optical imaging (IOI) for studying cerebral functions in vivo. The absorption 
spectra of oxy- hemoglobin (HbO) and HbR have different profiles in the visible and 
near-infrared spectrum. Thus measurements at different wavelengths provide temporal 
and spatial variations of HbO and HbR concentrations subsequent to sensory 
stimulation (Lieke et al. 1989). IOI requires a cranial window or thinned skull preparation 
which is illuminated by light and images of the reflected light are taken by a camera. 
Most of the signal detected with this method originates from the top 500 µm of cortex. 
IOI signals were extensively used to characterize the functional organization of the 
cerebral cortex (Grinvald et al. 1991) and the temporal profile of the hemodynamic 
response. Details of this methodology are further described in Paper 1. 
Near Infrared spectroscopy. Near infrared spectroscopy (NIRS) is based on the 
same principle as IOI, namely, near infrared light monitors changes in hemoglobin 
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concentration via absorption spectroscopy. The main advantage of NIRS lies in the 
ability to perform measurements through the intact skull and scalp. Therefore, NIRS 
enables bedside analysis as well as neurodevelopmental assessments in developing 
infants (Lloyd-Fox et al. 2010). 
Blood Flow 
Laser Speckle Contrast Imaging. Introduced in 1980, laser speckle contrast 
imaging (LSCI) is a powerful tool to study blood flow changes in the brain. When laser 
light is projected onto a brain area a speckle pattern is produced. This speckle pattern 
can be recorded with the use of a camera. The temporal and spatial intensity 
fluctuations of the speckle pattern contain information about movements of the 
scattering particles, in this case red blood cells (RBC). In case of no RBC movement, 
the speckle pattern appears homogeneous in the entire field and the contrast is 
maximal. In the presence of moving RBCs the speckle pattern is blurred, i.e. the 
speckle contrast is reduced. Spatial maps of relative blood flow are obtained by 
quantification of the contrast of the speckles. In terms of spatial and temporal resolution, 
LSCI is comparable to IOI (Dunn et al. 2001). Due to the ease of implementation, LSCI 
has been extensively used to study CBF response to spreading depression, in the retina 
and in the somatosensory cortex (Devor et al. 2012). 
Two-photon laser scanning microscopy. The introduction of 2PLSM has enabled 
scientists to measure CBF with a notably new approach. It allows depth-resolved 
monitoring of RBC velocities and vascular diameters in a microscopic fashion. Brain 
RBC velocity monitoring is obtained through a cranial window by labeling the blood 
plasma with a fluorescent dye (following intravenous injection). When the serum is 
labeled, RBCs appear as dark objects and by linear scanning along single vessels, 
temporal-spatial images are acquired. The individual scan lines are stacked upon each 
other, and from the slope of these black stripes, RBC velocity is calculated as shown in 
the figure 3 from Paper 2. 2PLSM studies have provided important results in the NVC 
field. For example, studies of the vascular architecture and of CBF reorganization upon 
experimental disruptions of the vascular network have been demonstrated (Kleinfeld et 
al. 1998). 
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Neuronal Imaging 
Voltage Sensitive Dye (VSD) imaging provides a visualization of brain cortical 
activity with 20-50 µm spatial resolution and a temporal resolution down to 1 millisecond 
(Chemla and Chavane 2010). The dye molecules, applied to the cortex surface through 
a cranial window, bind to the external membranes of neuronal and non-neuronal cells. 
Upon light excitation (630 nm) these cells emit fluorescent light, which is proportional to 
the changes in membrane potential. Due to its unique temporal resolution, VSD is ideal 
to monitor dynamics of cortical activity. However, the main limitation of this technique 
lies in the inability to identify the exact signal origin in different neuronal populations 
(excitatory or inhibitory) and non-neuronal cells (e.g. glia). 
Metabolic Imaging 
Phosphorescence lifetime imaging of oxygenation. Phosphorescence lifetime 
imaging of partial pressure of O2 (PLIO2) monitors oxygen-dependent phosphorescence 
lifetimes of an exogenous contrast agent. This technology has been used to measure 
cerebral intravascular and tissue oxygenation in vivo. Recently, PLIO2 has been 
combined with TPM (Sakadzic et al. 2009) in order to monitor cortical O2 delivery in 
tissue and deep microvasculature with unprecedented high spatial resolution. This 
cutting edge technology has been employed to measure partial pressure of O2 during 
sustained neuronal activation. The findings from Devor and colleagues (2011) indicate 
that the described overshoot in O2 (Raichle and Mintun 2006b) concentration during 
sustained stimulus-evoked activation may be a survival mechanism preventing hypoxia 
at the tissue level, where it is far away from the vascular feeding sources. 
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Chapter 2. Aims 
The study of basic mechanisms underlying NVC is a fascinating topic of research in 
neuroscience. Understanding how the active brain matches energy demands with local 
increases of blood flow is important for several reasons. Firstly, brain imaging 
techniques such as MRI and PET are now widely used in basic and clinical research. 
These techniques rely on NVC as a surrogate marker of brain activity. However, better 
understanding of the basic mechanisms of NVC is crucial to allow for clearer 
interpretation of obtained data. Secondly, NVC is disrupted in numerous neurological 
disorders and diseases such as hypertension. Better identification of the involved 
pathways could help to optimize treatments and improve patient outcomes. 
The research undertaken for this thesis is divided into two parts. The specific 
investigation of the involvement of astrocytes in normal NVC forms the first part. 
Secondly, we examined potential changes of the cerebral hemodynamic responses in 
hypertension.  
More specifically, in the first part, we wanted to investigate the following questions: 
1) Does activation of mGluR5 play a major role in the initiation of the hemodynamic 
response in the rat somatosensory cortex as postulated by earlier studies? 
2)  What is the effective mGluR5 receptor occupancy upon specifically blocking the 
receptors? 
3) What is the effect of mGluR5 blockade on the evoked neuronal activity? 
In the second part, effects of hypertension on NVC were investigated. Hypertension 
has been shown to impair NVC in animal and human studies. Hence, in our project we 
were interested in investigating the following questions: 
1) What is the influence of arterial HT on evoked hemodynamic responses? 
2) Does antihypertensive treatment with losartan or verapamil reverse possible 
alterations found in hypertensive animals?  
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3) How does chronically increased blood pressure influence resting CBF at the 
capillary level? What is the effect of losartan or verapamil treatment on CBF at the 
capillary level? 
4) Is there any evidence of structural or biochemical alterations as a consequence of 
arterial hypertension?  
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Chapter 3. Publications 
 
This chapter presents a compilation of the publications of the research performed 
during the PhD. Each paper is presented as published (or submitted). Papers are 
presented with their own introduction, methods, results and discussion sections.  
For each paper, I report at the beginning:  
• The publication journal (or if the manuscript has been submitted, the journal 
to which it is submitted to),  
• A list of citing papers, and 
• A list of congresses where the study was presented in poster format or as a 
talk.  
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Summary  
Recent years have seen a surge in research on the physiology of astrocytes. 
Several studies have suggested a role for astrocytes in the local control of cerebral 
blood flow and a comprehensive model has emerged in which neuronal processing 
activates the metabotropic glutamate receptor mGluR5 on astrocytes, triggering 
intracellular Ca2+ transients and leading to the activation of phospholipase A2. 
Phospholipase A2, in turn, activates a variety of pathways that ultimately leads to the 
astrocytic release of various vasoactive agents. Using concurrent optical imaging and 
determination of receptor occupancy with radiolabelled 11C-ABP688, we report here that 
blocking up to 80% of mGluR5 in vivo does not affect hemodynamic responses upon 
brief whisker stimulations while transiently reducing neuronal activity as measured by 
voltage-sensitive dye imaging. The results presented here strongly suggest that mGluR5 
does not play a crucial role in the transient phase of the hemodynamic response. This 
conclusion is supported by a large body of literature showing that: [i] expression of 
mGluR5 is mostly neuronal in physiological conditions and that it is significantly 
expressed in reactive glia; [ii] metabotropic receptors are in general responsible for slow 
postsynaptic signaling and it is still unclear whether this is compatible with the speed of 
early neurovascular events. Finally, other seemingly contradictory results have been 
reported, notably that spontaneous astrocytic Ca2+ surges are independent from 
metabotropic glutamate or purinergic receptors and that astrocytic Ca2+ increases are 
infrequent and delayed compared to the onset of vasodilation upon a variety of 
stimulation types in the rat or mouse somatosensory cortex. Thus, the exact mechanism 
by which astrocytes sense the extracellular glutamate concentration and trigger 
intracellular events for regulation of the vascular response remains unclear and 
research on this topic must continue. 
Abstract  
Activation of astrocytic mGluR5 is postulated to elicit calcium transients, triggering a 
chain of events that ultimately regulates cerebral blood flow by changing the tone of 
SMCs of nearby arterioles. Using concurrent in vivo optical imaging and determination 
of receptor occupancy with 11C-ABP688, we report here that blocking up to 80% of 
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mGluR5 in vivo does not affect transient hemodynamic responses upon brief whisker 
stimulations while transiently reducing neuronal activity as measured by voltage-
sensitive dye imaging. Our results demonstrate that mechanisms other than activation 
of mGluR5 are required to trigger the initial hemodynamic response in normal 
physiological conditions. 
 
Keywords 
astrocytes, neurovascular coupling, glutamate, G-protein-coupled receptor, 
metabotropic glutamate receptor mGluR5 
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Introduction 
Neurovascular coupling (NVC) refers to the relationship between local neural activity 
and subsequent changes in cerebral blood flow (CBF). First described by Mosso in 
1881 (1881), NVC ensures the proper supply of oxygen and nutrients to active brain 
regions and was subsequently shown to reflect the relaxation of vascular SMCs – and 
perhaps pericytes– of a specific brain area in response to a localized enhancement of 
neuronal activity. NVC is mediated by a complex flow of information among neurons, 
astrocytes, pericytes and the vasculature, which act in concert to maintain proper 
cerebral perfusion. 
Research in the field of NVC is highly relevant because it provides the basis for a 
better understanding of widely used functional imaging modalities based on CBF as a 
surrogate of neuronal activity. Furthermore, many of the most severe 
neurodegenerative diseases involve the vascular system as well as the supply of blood-
borne substrates and oxygen. Although the complex processes governing the regulation 
of local CBF are not completely understood and many important questions still 
unanswered, astrocytes have been identified in the last few years as key players in 
controlling local blood flow. Strategically located in an ideal position between neurons 
and vessels, astrocytes can integrate neurotransmitter signals from thousands of 
synapses (Bushong et al. 2002) and relay this information to the arterioles (Metea and 
Newman 2006). The specific close interactions among these different cell populations 
have led to the concept of a neuron-astrocyte-vasculature tripartite functional unit 
(Vaucher and Hamel 1995). 
One astrocytic pathway in particular has recently attracted a lot of attention. It has 
been reported that activation of the astrocytic metabotropic glutamate receptor mGluR5 
triggers Ca2+ transients in astrocytes (Wang et al. 2006) and affects NVC (Zonta et al. 
2003). Antagonists of group I metabotropic glutamate receptors (mGluR1 and mGluR5) 
were found to inhibit Ca2+ elevation in astrocytic endfeet and to reduce CBF increase in 
the somatosensory cortex of rodents upon forepaw stimulation (Zonta et al. 2003). It is 
postulated that these astrocytic Ca2+ transients lead in turn to the production and 
release of vasoactive prostaglandin E2 by astrocytes (Takano et al. 2006). The enzyme 
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phospholipase A2 mediates this mechanism. In the mouse olfactory bulb, the role of 
mGluRs in the regulation of NVC is still controversial. Gurden and colleagues (2006) 
discarded any involvement of metabotropic receptors in intrinsic signals evoked by 
odors and the local odor-evoked CBF functional increase was not affected by LY367385 
application to one glomerulus (Chaigneau et al. 2007). On the other hand, Petzold et al. 
(Petzold et al. 2008) have described a reduction of glomerular functional hyperemia 
upon topical application of MPEP and MCPG, respectively selective mGluR5 and 
unselective group I/II mGluR antagonists. 
mGluR5 is a G-protein-coupled receptor (GPCR) that plays a key role in the release 
of Ca2+ from internal stores via inositol triphosphate mobilization. It is highly expressed 
mainly in telencephalic regions, including the cerebral cortex, hippocampus, subiculum, 
olfactory bulbs and nucleus striatum (Ferraguti and Shigemoto 2006). High levels of 
astrocytic mGluR5 expression have also been observed in reactive glia and are thus 
often associated with non-physiological conditions (Aronica et al. 2000; Notenboom et 
al. 2006). Here, we report that pharmacological blockage of mGluR5 and mGluR1 does 
not affect NVC in the somatosensory cortex of adult anesthetized rats upon brief 
whisker stimulation of 4 and 24 seconds. Concurrent beta-probe measurements using 
the radiotracer 11C-ABP688, which binds with high specificity to the allosteric site of 
mGluR5 (Wyss et al. 2007), show that our protocol leads to a pharmacological receptor 
blockage of up to 80% in the somatosensory cortex, confirming blood-brain barrier 
passage and binding action of the drug. Under the same conditions, voltage-sensitive 
dye (VSD) imaging shows a transient reversible reduction of neuronal activity upon 
mGluR5 blockage within the first minutes. Taken together, these results suggest that 
mGluR5 activation does not play a significant role in the onset and possibly in the short-
term maintenance of the hemodynamic response in adult rats, and thus call for a 
revision of the current astrocytic model of NVC at these time scales. 
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Materials and Methods 
Animals 
The experiments were performed by licensed investigators and were approved by 
the local veterinary authorities. The animals (40 male Sprague Dawley rats weighing 
200 to 300 g) were provided by Harlan Laboratories (Netherlands) and were kept in 
cages in a ventilated cabinet with standardized conditions of light (night/day cycle: 12 
h/12 h) and temperature, and free access to food and water was permitted. To exclude 
a strain effect, additional experiments were conducted using Wistar rats (n=3); no 
difference was observed between the two strains (data not shown). 
Surgical preparation 
All surgical procedures were performed under isoflurane anesthesia (2.5% to 3.5%). 
Catheters (PE-50) were inserted into the right femoral artery and vein. For radiotracer 
measurements, the vessels of the left hindlimb were also cannulated for the placement 
of an arteriovenous shunt (av-shunt). The animals were tracheotomized and artificially 
ventilated. The skull above the barrel cortex (1 mm caudal and 3 to 6 mm lateral from 
Bregma) was carefully thinned using a dental drill (Bien Air Medical Technologies, 
Bienne, Switzerland). The thinned area was then covered with 2% agarose type III-A 
(Sigma, St Louis, MO, USA) in Ringer’s solution (in g/l: NaCl 8.6, CaCl2 0.30, KCl 0.30) 
and with a circular glass coverslip of 5-mm diameter. The animals’ temperature was 
kept at 37°C with a heating blanket and blood gases  were maintained within 
physiological ranges by adjusting the ventilation when necessary. After surgery, 
isoflurane was discontinued (or reduced to a maximum of 0.5% when necessary) and 
anesthesia was maintained with a first subcutaneous injection of α-chloralose (44 
mg/kg; Sigma) followed by continuous subcutaneous infusion (22 mg/kg/h). This 
anesthetic regime is considered ideal for studies of neurovascular and neurometabolic 
coupling (Bonvento et al. 1994). The level of anesthesia was controlled by observing 
arterial blood pressure during stimulation and by tail pinch. Experiments were performed 
after a postoperative recovery period of at least one hour to obtain a stable level of α-
chloralose anesthesia and stable imaging signals. 
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Sensory stimulation 
Following a baseline of 2 seconds, the vibrissae contralateral to the thinned skull 
were deflected using air puffs for 4 seconds at a frequency of 4 Hz. Ten trials were 
averaged for each sub-experiment. In an additional subset of experiments, after a 
baseline of 4 seconds, vibrissae were deflected for 24 seconds and five trials were 
averaged for each recording. For VSD experiments, a single whisker was deflected 
once and 10 trials were averaged for each condition. 
Intrinsic optical imaging 
Cortical images were acquired using two 12-bit CCD cameras (Pixelfly VGA, PCO 
Imaging, Kelheim, Germany) attached to a motorized epifluorescence stereomicroscope 
(Leica MZ16 FA, Leica Microsystems, Heerbrugg, Switzerland) focused 0.5 mm below 
the cortical surface. Two-dimensional optical spectroscopy was performed using the 
method described by Dunn et al. (2003a). The six wavelengths (560, 570, 580, 590, 600 
and 610 nm, 10 nm FWHM) were produced with a monochromator (Polychrome V, Till 
Photonics, Grafelfing, Germany) and coupled in the microscope using an optical fiber. 
Images were acquired with 30 Hz and the monochromator was synchronized with the 
image acquisition (each frame was acquired with a different illumination wavelength). 
The second camera was used to simultaneously measure CBF employing dynamic 
laser speckle imaging. The method is described in detail elsewhere (Zakharov et al. 
2009). 785-nm laser light (TuiOptics, Munich, Germany) was shone onto the cortex and 
images were acquired at 30 Hz with an exposure time of 10 ms. 
Pharmacological interventions 
6-Methyl-2-(phenylethynyl)-pyridine (MPEP) and LY367385 were supplied by Tocris 
Bioscience and injected i.v. at 1.2 mg/kg body weight or 4.0 mg/kg as specified in the 
text (dissolved in DMSO, DMSO reaching a maximum of 2% of the final concentration in 
NaCl). 6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX, Tocris Bioscience) was injected at 
15 mg/kg body weight (1:1 polyethylene glycol:NaCl). 2-(3-Methoxy-phenylethynyl)-6-
methyl-pyridine (M-MPEP), provided by Dr. Fabrizio Gasparini, was administered i.v. at 
different concentrations (in a range from 1 to 8 mg/kg, as specified in the text; 1:1 
 Paper 1 
51 
polyethylene glycol:NaCl). Both the MPEP and M-MPEP infusions were delivered at a 
very slow rate (approximately 0.2 ml/min). 
Radiotracer experiments 
11C-ABP688, a PET ligand for the study of mGluR5 (Wyss et al. 2007), was used for 
the determination of receptor density (Bmax) before and 10 minutes after injection of M-
MPEP. Radiotracer experiments included measurements of time courses of tracer 
accumulation in the left somatosensory cortex using a beta scintillator for surface 
acquisitions (Wyss et al. 2009) and the online acquisition of total arterial 11C activity in 
the av-shunt. For the latter purpose, the shunt was run through a coincidence counter 
(GE Medical Systems). The online arterial sampling procedure is described in detail 
elsewhere (Weber et al. 2002). Whole blood activity was then corrected for [i] the 
relative concentration of 11C-ABP688 in plasma versus whole blood and [ii] the 
concentration of labeled metabolites. 
For the tissue acquisitions, the scintillator was adjusted just above the thinned skull 
covering the somatosensory cortex. The count rate was stored on a personal computer 
using a bin width of 1 second, yielding tissue time-activity curves. During both 
conditions (baseline/blockage), data were acquired for 20 minutes. Following each 
experiment, the beta scintillator was calibrated with a known concentration of 11C 
activity. Injected activities were in the range of 40–104 MBq throughout all experiments 
and the injected mass of ABP688 was 0.49–4.08 pmol/g body weight. This methodology 
used to quantify mGluR5 using 11C-ABP688 is described in detail elsewhere (Wyss et 
al. 2007). 
VSD imaging 
For VSD imaging, the dye RH1691 was dissolved at 1 ml/ml in Ringer’s solution. A 
cranial window was drilled on the right hemisphere above the whisker barrel cortex 
(Bregma, 0 to -5 mm; lateral, 2–7 mm). After removal of the bone, dura was left intact to 
reduce movement artifact and tendency to edema. Around the craniotomy, a few layers 
of dental cement were applied to form a trough to prevent dye leakage during the 
staining process. The dye was topically applied and was allowed to diffuse into the 
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cortex for 90 minutes. During staining, the dye was continuously circulated by a 
peristaltic pump (Reglo digital, Ismatec SA, Glattbrugg, Switzerland). Thereafter, the 
unbound dye was removed and the area was washed with dye-free Ringer’s solution for 
more than 15 minutes. The fluid-filled chamber was then covered with a glass coverslip. 
For imaging, the dye was excited with 630-nm light from a LED lamp (Thorlabs GmbH, 
Dachau/Munich, Germany). The excitation light was reflected by a 650-nm dichroic 
mirror and focused onto the cortical surface with a camera lens. Fluorescent emission 
light was collected via the same optical pathway, but without mirror reflection, long-pass 
filtered (>670 nm) and focused onto the sensor of a high-speed Micam Ultima camera 
(Scimedia, California, USA). This high-speed CMOS-based camera has a detector of 
100 × 100 µm. Images were collected with 1-ms temporal resolution. Acquisitions were 
performed before and 5, 15, 30, 45 and 60 minutes after the i.v. injection of 4 mg/kg M-
MPEP. Due to the high sensitivity of the VSD method, the VSD signal was elicited by a 
single whisker deflection. 
Data analysis 
Image analysis and radiotracer kinetic analysis were performed using custom-written 
Matlab routines and the software package PMOD (Mikolajczyk et al. 1998b). 
Optical imaging. The analysis of the multiwavelength spectroscopy followed the 
protocol of Dunn and colleagues (2003a). Baseline values for total hemoglobin 
concentrations were set to 100 µM with 70% oxygen saturation, which implies HbO0 70C =
µM and HbR0 30C = µM. To quantify CBF, speckle images were processed as described 
recently (Zakharov et al. 2009) using 5 × 5 spatial and 25 temporal binning. Circular 
regions of interest (0.5 mm2) were drawn manually over the area of maximal signal 
increase to extract the signal time courses. The 10 trials (5 in long-term stimulation 
experiments), that were carried out within 12 minutes in each animal, were averaged. 
All data represent the mean ± standard error of the mean used for each experimental 
condition. Spectroscopic and CBF maximum signals in the presence of pharmacological 
intervention were normalized to the control condition. 
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11C-ABP688 radiotracer kinetic modeling. The applied methods consisted of 
standard compartmental modeling using an arterial input function. Tracer kinetics were 
modeled using a two-tissue compartment model with rate constants K1–k4, which has 
been shown to be suitable for the description of 11C-ABP688 data (Wyss et al. 2007). To 
achieve stable fits, K1/k2 and k4 were fixed at 1.6 and 0.05 min-1, respectively, for both 
conditions (baseline/blockage), corresponding to mean values of free fitting using two 
tissue compartments. For data analysis, background counts were subtracted and all 
time-activity curves were decay corrected (physical half-life = 20.38 minutes) to the time 
point of injection and converted to kBq/ml taking into account a determined calibration 
factor (see above). For details of the analysis procedure, see the previous description of 
the approach (Wyss et al. 2007). 
VSD. Bleaching of fluorescence was corrected by subtraction of a best-fit double-
exponential. Time courses of fluorescence changes were quantified as ∆F/F0 from 
circular regions of interest of constant diameter adjusted to the activation area. In order 
to compare VSD signals from different animals, regions of interest were centered on the 
location of the earliest response. Amplitude was defined as the difference between the 
maximal response and the baseline signal just before the onset of whisker stimulation. 
Within single studies, amplitude changes across acquisitions were normalized to the 
signal amplitude of the baseline examination (=acquisition before M-MPEP injection). 
Statistics. The required sample size was estimated prior to the study based on 
published data (Zonta et al. 2003), where a CBF response of 23 ± 7.0% (mean ± 
standard error of the mean; n=5) was reduced to 8 ± 1.8% by mGluR blockage. The 
authors report that a t-test for paired samples yielded p<0.01, from which follows t≥4.6 (df=4) 
and effect size d≥2.05. Based on these parameters, a minimum sample size of n=8 was 
determined (Software G*power, University of Düsseldorf, Germany). Differences between 
hemodynamic responses before and after receptor blockage were statistically analyzed 
using the Wilcoxon signed-rank test. 
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Results 
To control for the role of mGluR5 in the regulation of CBF, we assessed NVC before 
and after pharmacological manipulations of the receptor. More specifically, we used 
multiwavelength spectroscopy to reveal quantitative spatiotemporal changes of 
deoxyhemoglobin (HbR), oxyhemoglobin (HbO) and total hemoglobin (HbT) 
concentrations. Concurrently, we used laser speckle contrast imaging maps to measure 
relative CBF changes (Zakharov et al. 2009). 
Transient hemodynamic responses of the somatosensory cortex are not affected 
by mGluR5 blockage 
Figure 1A shows a typical hemodynamic response of the somatosensory cortex 
upon brief whisker stimulation with co-localized changes in HbR, HbO, HbT and CBF. 
Spatiotemporal hemodynamic and metabolic responses were measured in a series of (i) 
control experiments (n=5 animals), and in the absence and presence of 
pharmacological intervention using (ii) MPEP and LY367385 (n=7 animals), (iii) M-
MPEP (n=8 animals) and (iv) CNQX (n=6 animals). To investigate the effect of group I 
mGluR block on NVC, MPEP and LY367385 (mGluR5 and mGluR1 blockers, 
respectively) were administered i.v. (1.2 mg/kg). These compounds readily pass 
through the blood-brain barrier (Gasparini et al. 2002; Gasparini et al. 1999). 
Surprisingly, no significant changes were observed in the evoked hemodynamic 
responses following blockage of these mGluRs (Fig. 1B and C). To further confirm 
these results, we studied the effect of a more effective mGluR5 blocker, M-MPEP, which 
is five times more potent than MPEP (Gasparini et al. 2002; Gasparini et al. 1999). 
Again, no significant reduction of evoked hemodynamic signals was observed between 
baseline condition and 10 minutes after M-MPEP pharmacological intervention (Fig. 1B 
and C). On the other hand, the CBF signal was slightly but significantly increased by M-
MPEP injection. In a separate set of animals, hemodynamic responses were evaluated 
before and 10 minutes after systemic injection of CNQX, an AMPA/kainate receptor 
antagonist. The neuronal activity block elicited a significant reduction in all 
hemodynamic parameters and in CBF. 
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Paper 1 Figure 1. Application of group I mGluR antagonists does not affect NVC upon brief whisker 
stimulation. 
Relative changes of deoxy- (HbR), oxyhemoglobin (HbO) and blood volume (HbT) upon brief whisker stimulation 
were measured by optical spectroscopy in the activated barrel cortex while CBF was measured by laser speckle 
imaging. (B) Average responses after i.v. injection of the mGluR5 and mGluR1 antagonists MPEP and LY367385, 
respectively (1.2 mg/kg; pink), and after injection of M-MPEP (four animals at 1 mg/kg; one animal at 2 mg/kg; one 
animal at 3 mg/kg and two animals at 4 mg/kg; red) compared to baseline (black). Data shown were recorded 10 
minutes after drug injection. No significant decrease of the response was observed after these treatments (statistical 
testing either for the MPEP-LY367385 and M-MPEP groups separately or for the two groups pooled together, n=15). 
In contrast, after treatment with CNQX (15 mg/kg; green; n=6), a strong reduction in the hemodynamic signals was 
evident. (C) Peak deviations normalized to baseline (mean ± sem; *p<0.05, †p=0.075, Wilcoxon signed-rank test). In 
total MPEP-LY367385, MMPEP and CNQX were tested, respectively, in 7, 8, 6 rats. Measurements at the later time 
points (30 and 45 minutes) did not show any significant decrease of the peak response (data not shown). 
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Steady-state hemodynamic responses are not affected by blockage of group I 
mGluRs 
After demonstrating that group I mGluR block does not affect NVC mechanisms 
during brief whisker stimulation, we wanted to explore the contribution of mGluR5 to 
more sustained blood flow responses. Hemodynamic responses before and after 
injection of group I mGluR antagonists were evaluated in four animals during 24 
seconds of whisker stimulation. Stimulus-evoked responses exhibited an initial peak 
followed by a steady-state component that lasted until the stimulation was discontinued 
(Fig. 2A). Similar responses have been previously reported (Berwick et al. 2008). Both 
the initial peak and the steady-state component did not exhibit any change after MPEP 
and LY367385 i.v. injection (4.0 mg/kg) as reported in CBF example curves (Fig. 2A). 
On the contrary, a brief systemic increase in mean arterial blood pressure was recorded 
(significantly different only during the first 5 minutes after systemic injection; p<0.05, 
Paper 1 Figure 2. The NVC response during longer 
stimulation is also not affected by group I mGluR 
antagonists MPEP and LY367385. 
(A) Example of CBF recordings during 24-second whisker 
stimulation before (black) and 10 minutes after (pink) MPEP 
and LY367385 i.v. injection (4.0 mg/kg). (B) Systemic effect 
on mean arterial blood pressure (MAP) evoked by MPEP 
and LY367385 i.v. injection (4.0 mg/kg). Five minutes after 
drug injection, a significant increase was observed (MAP 
before injection: 101 ± 11 mmHg; 5 min after injection: 120 ± 
4; 45 min after injection: 111 ± 11; mean ± sd; n=4; *p<0.05, 
Wilcoxon signed-rank test) before the arterial blood pressure 
returned to its baseline. This transient increase was not 
elicited by placebo injection (see text).  
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Fig.2B), which was not observed during placebo experiments (same volume of 1:1 
polyethylene glycol:NaCl; data not shown). 
Intravenous injection of mGluR5 antagonists leads to high levels of receptor 
occupancy 
Next, we verified that the administration of MPEP and M-MPEP did indeed 
significantly block mGluR5 in our protocol. To this end, we conducted a series of 
concurrent optical/radiotracer experiments to quantify cortical mGluR5 occupancy and 
its effect on the hemodynamic response (n=5). Using 11C-ABP688, both MPEP and M-
Paper 1 Figure  3. Delivery of M-MPEP leads to blockage of mGluR5 in the rat somatosensory cortex but fails 
to attenuate the hemodynamic response. 
After the injection of M-MPEP (4 mg/kg), the washout of radiolabel from tissue was increased (B) compared to 
baseline condition (A) as represented by the decay-corrected tissue time-activity curves (blue circles). The model 
curve (blue line) and the radioactivity concentration in plasma (i.e. input curve; red line) are also shown. The full 
range of data is displayed in the insets (same axes legends). In this example, the estimated mGluR5 blockage 
amounted to 47%. (C) Hemodynamic response upon stimulation (gray area) before (black line), 10 minutes (red line) 
and 30 minutes (broken red line) after delivery of M-MPEP (same experiment as in A and B) was unaffected by 
mGluR5 blockage. In (D), the density of receptors in the tissue (Bmax) is shown for all individual beta-probe 
experiments before and after blockage (square: 1.2 mg/kg MPEP/LY367385; circle: 1 mg/kg M-MPEP; diamond: 4 
mg/kg M-MPEP; triangle: 8 mg/kg M-MPEP). White boxes represent mean ± sd (*p<0.05, Wilcoxon signed-rank test). 
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MPEP were found to significantly reduce radiolabel binding to the tissue compared to 
baseline condition, without having a noticeable effect on the hemodynamic response 
(Fig. 3). Radiotracer activity was recorded for a period of 20 minutes, beginning 10 
minutes after MPEP or M-MPEP injection. On average, a 57% reduction in the density 
of free receptors in the tissue was measured (Bmax; Fig. 3D). 
Evoked neuronal activity in the somatosensory cortex is transiently reduced by 
mGluR5 blockage 
In order to assess the potential impact of mGluR5 blockage upon neuronal activity, 
and in particular to control for changes in the spatiotemporal dynamics of cortical brain 
activity upon mGluR5 blockage by M-MPEP, VSD experiments were performed. VSD 
imaging provides a visualization of the cortical activity of a large neuronal population in 
the upper cortical layers with high spatial and temporal resolution (Chemla and 
Chavane 2010). VSD fluorescent signals evoked by a single whisker deflection were 
recorded in control conditions and after M-MPEP i.v. injection (4 mg/kg, n=6). The VSD 
signal was slightly decreased, on average by 27% 5 minutes after M-MPEP injection 
(Fig. 4). Measurements at later time points revealed this effect to be completely 
reversible, indicating a transient reduction in neuronal activity in response to mGluR5 
block. 
Paper 1 Figure 4. Neuronal activity slightly decreases 
during the first 30 minutes after mGluR5 blockage. 
(A) Maps of a single VSD imaging experiment performed 
before (top), 5 minutes (middle) and 45 minutes (bottom) 
after injection of M-MPEP (4 mg/kg). Single frames are 5 
ms apart from each other. The series starts 5 ms before 
single whisker stimulation evoked at time 0. (B) Summary 
of VSD results in six animals. After only 5 minutes 
following the injection of M-MPEP (4 mg/kg), the 
amplitude of the VSD signal significantly decreased by, 
on average, 27%. At later time points, the signal was not 
significantly different from baseline level; *p<0.05, 
Wilcoxon signed-rank test). 
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Discussion 
Recent years have seen a surge in research on the physiology of astrocytes, and 
the regulation of local CBF is one of the areas where a relatively comprehensive model 
involving astrocytes has been suggested (Attwell et al. 2010). This model proposes that 
the activation of astrocytic metabotropic glutamate receptor mGluR5 by neuronal activity 
triggers intracellular Ca2+ transients, leading to the activation of phospholipase A2. 
Phospholipase A2, in turn, activates a variety of pathways that ultimately lead to the 
release of possibly multiple vasoactive agents by astrocytes. The work presented here 
contradicts this model. More specifically, it contradicts the involvement of mGluR5 in 
triggering this complex chain of events. We have reported here that, even though 
antagonists of mGluR5 delivered intravenously cross the blood-brain barrier and block 
up to 80% of the receptors (Fig. 3), they fail to induce a reduction of the hemodynamic 
response upon brief 4- and 24-second whisker stimulation (Figs. 1 and 2). However, it 
was found that mGluR5 antagonists provoke a transient increase in mean arterial blood 
pressure (Fig. 2) and a transient reduction of neuronal activity (Fig. 4). Additionally, 
injection of mGluR5 antagonists did not significantly affect the baseline cerebral blood 
flow which could have interacted with the hemodynamic response following the 
stimulation (data not shown). 
As mentioned above, several studies have reported a reduction of the hemodynamic 
response upon blockage of mGluR5 (Petzold et al. 2008; Takano et al. 2006; Zonta et 
al. 2003). Activation of mGluR5 has also been reported to elicit Ca2+ transients in 
astrocytes (Wang et al. 2006). The present study differs from these studies in three 
ways. First, we used relatively brief whisker stimulations (4 and 24 seconds), whereas a 
60-second stimulation was normally applied in these studies. Secondly, we used a 
thinned skull preparation to keep the system as intact and healthy as possible. Finally, 
we used a combination of intrinsic optical imaging and laser speckle imaging, whereas 
in the earlier studies CBF was measured with a laser Doppler probe. This last point, 
however, should not affect the results. Despite the fact that laser speckle imaging maps 
CBF in two dimensions and laser Doppler flowmetry is normally a point measurement, 
both techniques essentially rely on the same physical principles. 
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It is important to note that we probed the system in a time frame comparable to the 
one used in other studies. For example, Zonta et al. (2003) measured the effect of 
MPEP injection on CBF 15 to 20 minutes after injection. Our results show a very 
significant receptor occupancy 10 to 30 minutes after MPEP or M-MPEP injection (Fig. 
3), yet still no reduction in the hemodynamic response. In principle, the transient 
decrease in neural activity reflected by the decrease in VSD signal amplitude (Fig. 4) 
should lead to a detectable reduction of the hemodynamic signal in the first few minutes 
after injection. One possible explanation of the absence of a hemodynamic effect is an 
interaction with the observed transient increase in systemic arterial blood pressure. A 
limitation of the present study is the fact that the stimulation protocols used for the VSD 
and hemodynamic imaging were not identical. Further investigation of this phenomenon 
will require a simultaneous acquisition of both signals to detect possible interactions on 
the single trial level. 
Blockage of mGluR5 by injection of the potent M-MPEP slightly but significantly 
increased the evoked CBF response (Fig. 1C). It is difficult to give a simple explanation 
for this result as mGluR5 plays a role in a variety of physiological processes, some of 
them of systemic nature, as reflected by the transiently elevated blood pressure.  
Part, but not all, of the apparent contradiction between our data and previous reports 
could be explained by regional differences in the expression pattern of mGluR5, e.g. the 
study by Petzold and colleagues (Petzold et al. 2008) focused on the olfactory bulb. 
However, the question remains open whether or not astrocytic mGluR5 plays a role in 
NVC. We note that the literature does not unequivocally support a key physiological role 
for astrocytic mGluR5 in functional hyperemia. The arguments are as follows. 
First, it appears that expression of mGluR5 is mostly neuronal but that it can also be 
highly expressed in reactive glia. mGluR5 immunoreactivity has been reported in 
neurons, in axons or in vesicles (Jia et al. 1999), and the receptor is indeed widely 
expressed by neurons in adult rodents (Ferraguti and Shigemoto 2006). In support of 
these results, knocking out mGluR5 only in cortical excitatory neurons strongly reduces 
its overall expression level in the cortex (Ballester-Rosado et al. 2010). Moreover, in the 
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cerebral cortex, all non-neuronal cells were found to be negative for mGluR5 by Mudo 
and colleagues (2007). Even though mGluR5 has been reported in hypothalamic (Van 
Den Pol et al. 1995) and cultured (Biber et al. 1999) astrocytes, high levels of astrocytic 
mGluR5 expression have been observed in reactive glia and are thus often associated 
with non-physiological conditions (Aronica et al. 2000; Notenboom et al. 2006). 
Consistent with this view, mGluR5 expression is increased in vitro in the presence of 
growth factors, such as transforming growth factor α and epidermal growth factor, in the 
extracellular environment (Miller et al. 1995). 
Secondly, GPCRs are in general responsible for slow postsynaptic signaling. In a 
recent review, Cauli and Hamel (2010) discuss the temporal sequence of astrocytic and 
neuronal contributions to CBF control. In both neurons and astrocytes, intracellular Ca2+ 
increases code neuronal activity and elicit several cascades of events. Neurons express 
ionotropic receptors more frequently and abundantly than astrocytes and consequently 
are able to evoke quick changes in membrane potential, inducing rapid intracellular 
Ca2+ increases in a time window of about 10–12 ms. On the contrary, due to their signal 
trasduction pathways,  metabotropic receptors in general elicit responses of slower 
onset and longer duration, from seconds to potentially hours, although GPCR mediated 
synaptic responses can occur at relatively fast timescales of 1 to 2 seconds upon strong 
stimulation (Charpak and Gahwiler 1991).  Even though these faster responses are 
compatible with functional hyperemia, it seems more likely that group I mGluRs 
expressed in either neurons and/or astrocytes are responsible for the slow components 
of Ca2+ dynamics (Cauli and Hamel 2010). In different in vivo studies (Devor et al. 2008; 
Takano et al. 2006; Weber et al. 2004) and in the data reported here, a hemodynamic 
delay of about 500 ms was observed, indicating that the transient phase of the 
hemodynamic response, if it is Ca2+-induced, is likely to be initiated by cells with fast 
Ca2+ dynamics. Astrocytes, which only in a small portion exhibit Ca2+ responses as fast 
as in neurons (Winship et al. 2007), potentially contribute to NVC regulation only in the 
later response phase. 
Finally, other groups have also reported findings contradicting the mGluR5 astrocytic 
model. Takata and Hirase have reported that astrocytic spontaneous Ca2+ surges are 
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not affected by MPEP systemic injection or pyridoxalphosphate-6-azophenyl-2’,4’-
disulfonic acid (PPADS, a non-selective P2 purinergic antagonist) topical application in 
L1 and L2/3 of the somatosensory cortex of anesthetized rats (Takata and Hirase 
2008), indicating that the spontaneous astrocytic Ca2+ surges are independent of 
metabotropic glutamate or purinergic receptors. More recently, the group of A. Devor 
reported that astrocytic Ca2+ increases are infrequent and delayed compared to the 
onset of vasodilation upon a variety of stimulation types in the rat or mouse 
somatosensory cortex (Nizar et al. 2010). Taken together, these studies are not 
supportive of a predominant role for astrocytic mGluR5 in triggering the fast initial 
hemodynamic response and do not support the notion that the transient neurovascular 
response is mediated through a Ca2+-related mechanism. However, our results and the 
literature cited above do not rule out a possible involvement of mGluR5 in the late 
maintenance phases of the hemodynamic response, which would then explain why 
other groups have observed a reduction of the neurovascular response upon MPEP 
delivery after longer periods of stimulation (30–60 seconds). However, at least for the 
whisker-to-barrel system, such long lasting activity patterns are rather artificial and rapid 
neuronal adaptation already occurs after a few seconds following stimulation onset. 
The results presented here strongly suggest that mGluR5 does not play a crucial role 
in the transient phase of the hemodynamic response. Thus, the exact mechanism by 
which astrocytes sense the extracellular glutamate concentration and trigger 
intracellular events for regulation of the vascular response remains unclear and 
research on this topic must be continued. 
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Abstract  
Background – Arterial hypertension is an important risk factor for cerebrovascular 
disease such as transient ischemic attacks or stroke, and represents a major global 
health issue. The effects of hypertension on cerebral blood flow (CBF), particularly at 
the microvascular level, remain unknown. 
Methods and Results – Using the spontaneously hypertensive rat (SHR) model, we 
examined the cortical hemodynamic response upon whisker stimulation applying a 
multimodal imaging approach (multiwavelength spectroscopy, laser speckle imaging, 
two-photon microscopy). We assessed the effects in 10-, 20-, and 40-week-old male 
SHRs and age-matched male Wistar Kyoto rats (CTRL) with regard to hemodynamic, 
histological, and biochemical parameters. Losartan and verapamil were administered for 
10 weeks to test the reversibility of hypertension-induced impairments. Compared with 
CTRLs, increased arterial blood pressure in SHRs was associated with a progressive 
decrease in functional hyperemia in 20- and 40-week-old SHRs; baseline capillary red 
blood cell velocity was increased in 40-week-old SHRs. Antihypertensive treatment 
reduced baseline capillary CBF almost to CTRL values, while functional hyperemic 
signals improved only slightly. Structural analyses of the microvascular network 
revealed no differences between normo- and hypertensive animals, whereas expression 
analyses of cerebral lysates showed signs of increased oxidative stress in hypertensive 
rats and signs of impaired endothelial homeostasis upon early hypertension. 
Conclusions – Impaired neurovascular coupling in the SHR evolves upon sustained 
hypertension. Antihypertensive mono-therapy using verapamil or losartan is not 
sufficient to abolish this functional impairment. These deficits in neurovascular coupling 
in response to sustained hypertension might contribute to accelerated progression of 
neurodegenerative diseases in chronic hypertension. 
 
Keywords: Hypertension, brain, rats, neurovascular coupling, multimodal imaging, 
cerebral blood flow. 
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Introduction 
Arterial hypertension (aHTN) accounts for more than one third of deaths in Western 
countries (Lawes et al. 2008). High blood pressure strongly affects the brain which 
depends on the continuous blood-borne supply of oxygen and energy substrates in a 
timely and localized manner. It constitutes one of the major risk factors for hemorrhagic 
stroke (Goldstein et al. 2006) and is a leading cause of dementia and cognitive 
impairments (Dahlof 2007). 
At the functional level, high blood pressure disrupts the regulatory mechanisms 
underlying neurovascular coupling (NVC) (Iadecola and Davisson 2008) and impairs 
cerebral blood flow (CBF) autoregulation (Paulson et al. 1990). From a structural point 
of view, aHTN induces a reduction in gray matter thickness as well as an increased 
ventricular size due to brain atrophy (Jennings and Zanstra 2009). Furthermore, aHTN 
induces vascular hypertrophy with a consequent reduction of lumen diameters and 
increased rigidity of the arterial walls. aHTN is also associated with a loss of arterioles 
and capillaries (Boegehold 2007). 
The effects of aHTN on brain hemodynamics have been investigated in several 
animal studies yielding contradictory results. These may depend on strains, anesthetic 
conditions, and whether the study assessed evoked signals or resting conditions. For 
instance, resting CBF in spontaneously hypertensive rats (SHR) has been reported to 
be similar to (Wei et al. 1992), less than (Katsuta 1997), or greater than (Heinert et al. 
1998) that of controls (Wistar Kyoto rats). More recently, no differences in resting CBF 
were observed between Wistar Kyoto rats and SHRs under α-chloralose anesthesia at 
either 3 or 10 months of age and in different brain areas (Leoni et al.). In another model 
where aHTN was induced by systemic injection of angiotensin II (Capone et al. 2012), 
CBF responses evoked by whisker stimulation were reduced in hypertensive animals in 
comparison to normotensive mice. In human positron emission tomography studies, 
aHTN appears to induce a mild dampening in regional CBF response during memory 
tasks, more pronounced in frontal and subcortical regions (Jennings et al. 2005). 
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The prevalence of aHTN increases with age, which may also affect CBF and 
NVC. In human positron emission tomography studies, aging is usually associated with 
a significant decrease in resting CBF (Bentourkia et al. 2000). In addition, aging is 
accompanied by a reduction in the blood oxygenation level-dependent response (Ances 
et al. 2009). Similarly, Dubeau and colleagues have recently reported a reduced 
hemodynamic response in the somatosensory cortex of aged rats (24 and 40 months) 
with unaltered metabolic rate of oxygen (Dubeau et al. 2011). 
The influence of sustained aHTN on NVC has never been studied by means of a 
multimodal brain imaging approach in a model of essential genetic aHTN such as the 
SHR. SHRs provide a unique animal model for studying chronic essential aHTN, 
superseding pharmacological intervention to increase blood pressure. The animals are 
normotensive at birth and develop severe systolic and diastolic aHTN in the first 2–4 
months of life. At 6 months, they show established sustained aHTN (Amenta et al. 
2003). 
In the present study, we investigated the effects of sustained aHTN of variable 
duration on the hemodynamics and structure of the somatosensory cortex in SHRs. In 
the second phase, we examined the reversibility of alterations by antihypertensive 
treatment. We found a reduced stimulation-evoked hemodynamic response in the 
somatosensory cortices of 20- and 40-week-old male SHRs when compared with age-
matched and sex-matched normotensive controls. These functional changes of NVC 
were paralleled by structural changes such as decreased cortical thickness and 
increased ventricle size, and biochemical alterations such as signs of increased 
oxidative stress and altered endothelial homeostasis. In contrast, we did not detect any 
structural changes in the cerebral microvascular system. Antihypertensive treatment 
using losartan or verapamil decreased blood pressure and normalized baseline capillary 
blood flow, but did not improve CBF response. 
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Materials and Methods 
Animals 
All experimental procedures were reviewed and approved by the local ethical 
committee and the cantonal veterinary authority. They conform to the guidelines of the 
Swiss Animal Protection Law, Veterinary Office, Canton Zurich (Act of Animal Protection 
of December 16, 2005 and Animal Protection Ordinance of April 23, 2008). The animals 
were provided by Harlan Laboratories (Blackthorn, UK) and were kept in cages in a 
ventilated cabinet with standardized conditions of light (night/day cycle: 12 h/12 h) and 
temperature, and free access to food and water was permitted. 
Male rats of three different ages were examined in this study: 10, 20, and 40 weeks. 
At each age, SHRs were compared to age-matched Wistar Kyoto rats serving as 
normotensive controls (CTRL). In the 10 and 20 weeks groups, SHRs and CTRLs were 
directly compared. The 40 weeks group was divided into four subgroups: [i] CTRLs, [ii] 
untreated SHRs, [iii] SHRs treated for 10 weeks with losartan (LOS), and [iv] SHRs 
treated for 10 weeks with verapamil (VER). 
Surgical preparation 
All surgical procedures were performed under isoflurane anesthesia (2.5–3.5%). 
Catheters (PE-50) were inserted into the right femoral artery and vein. Animals were 
tracheotomized and artificially ventilated. The skull above the left barrel cortex (1 mm 
caudal and 3 to 6 mm lateral from bregma) was carefully thinned to translucency using 
a dental drill (Bien-Air Medical Technologies, Bienne, Switzerland). The thinned area 
was then covered with 2% agarose type III-A (Sigma-Aldrich, Buchs, Switzerland) in 
Ringer’s solution (in g/l: NaCl 8.6, CaCl2 0.30, KCl 0.30) and a circular glass coverslip of 
5 mm diameter. The animal’s temperature was kept constant at 37°C with a heating 
blanket and blood gases were maintained within physiological ranges by adjusting the 
ventilation when necessary. After surgery, isoflurane was discontinued (or reduced to a 
maximum of 0.4% when necessary) and anesthesia was maintained with an initial 
subcutaneous injection of α-chloralose (44 mg/kg; Sigma-Aldrich) followed by 
continuous subcutaneous infusion (22 mg/kg/h). This anesthetic regime is considered 
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ideal for studies of neurovascular and neurometabolic coupling (Bonvento et al. 1994). 
Intrinsic optical imaging experiments were performed after a post-operative recovery 
period of at least one hour in order to achieve a stable level of α-chloralose anesthesia 
and stable imaging signals. 
Sensory stimulation 
Following a baseline of 2 seconds, a single vibrissa contralateral to the thinned skull 
was deflected for 4 seconds at a frequency of 4 Hz. 
Intrinsic optical imaging 
Data were acquired following the method previously described by our group 
(Calcinaghi et al. 2011). Cortical surface images were acquired using two 12-bit CCD 
cameras (Pixelfly VGA, PCO Imaging, Kelheim, Germany) attached to a motorized 
epifluorescence stereomicroscope (Leica MZ16 FA, Leica Microsystems, Heerbrugg, 
Switzerland) focused 0.5 mm below the cortical surface, as previously described in 
(Calcinaghi et al. 2011; Goldstein et al. 2006). Two-dimensional optical spectroscopy 
was performed using the method described by Dunn and colleagues (Dunn et al. 2003b; 
Dunn et al. 2005). The six wavelengths (560, 570, 580, 590, 600 and 610 nm, 10 nm full 
width at half maximum) were produced with a monochromator (Polychrome V, Till 
Photonics, Grafelfing, Germany) and coupled in the microscope using an optical fiber. 
Images were acquired at 30 Hz and the monochromator was synchronized with the 
image acquisition (each frame was acquired with a different illumination wavelength). 
The second camera was used to simultaneously measure CBF employing dynamic 
laser speckle imaging. The method is described in details elsewhere (Zakharov et al. 
2009). 785-nm laser light (TuiOptics, Munich, Germany) was shone onto the cortex and 
images were acquired at 30 Hz with an exposure time of 10 ms per image. A scheme of 
the intrisic optical set up is reproduced in Figure 1C. 
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Paper 2 Figure 1. Example images and signals obtained by Intrinsic optical imaging and laser specke. 
A, Activation maps of deoxy- (HbR), oxy- (HbO), and total hemoglobin (HbT) as well as cerebral blood flow (CBF) 
upon single whisker stimulation (4 Hz during 4s). Hemoglobin reflectance changes were measured by optical 
spectroscopy while CBF was measured by laser speckle imaging. B, Typical relative changes in HbR, HbO, HbT and 
CBF corresponding to the ROI in A (gray bar marks the stimulation period). C, Schematic of the setup for 
multiwavelength spectroscopy and laser speckle imaging. 
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Two-photon laser scanning microscopy 
Following the camera-based optical imaging session, the skull and dura mater above 
the activated cortical area were removed. The cortex was stained for 5 minutes with the 
fluorescent astrocyte marker sulforhodamine 101 (Sigma-Aldrich). The barrel cortex 
was then washed with saline for 10 minutes and covered with 2% agarose type III-A in 
Ringer’s solution and with a circular glass coverslip. Two-photon laser scanning 
microscopy was performed using a custom-built microscope equipped with a 16× 
objective (Haiss et al. 2009). Blood plasma was labeled with a 0.5 ml bolus of 5% 
fluoresceinisothiocyanate-labeled dextran (10 kDa; Sigma-Aldrich) dissolved in 
physiological saline. Line scans of straight capillary segments were acquired at 800 Hz. 
Drug treatment 
Antihypertensive treatment was administered to SHRs at the age of 30 weeks for a 
period of 10 weeks, either with VER (80 mg/kg/day (Fortepiani et al. 1999); Sigma-
Aldrich) or LOS (30 mg/kg/day (Gohlke et al. 1996); Sigma-Aldrich). Both drugs were 
dissolved in the drinking water and solutions were freshly prepared each day. During 
the treatment period, blood pressure was monitored by regular tail cuff measurements 
(data not shown). 
Immunohistochemistry 
After the functional imaging measurements, rats were deeply anesthetized with 
pentobarbital (pentobarbital-Na; 60 mg/kg, i.p.) and perfused transcardially with ice-cold 
fixative (0.15 M sodiumphosphate buffer, 4% paraformaldehyde, pH 7.4). Brains were 
removed immediately after perfusion, post-fixed for 2 hours at 4°C, and impregnated 
overnight with 30% sucrose in PB (Phosphate Buffer) for cryoprotection. Transverse 40-
µm-thick sections were cut from frozen blocks with a sliding microtome and collected in 
PBS (Phosphate-buffered Saline). Sections were then stored in antifreeze solution (50 
mM PB, 15% glucose, 30% ethylene glycol, sodium azide, pH 7.4) at –20°C until use. 
Nissl staining. A 1:6 series of sections was Nissl stained with cresyl violet to 
measure lateral ventricle sizes and cortical thicknesses within the different animal 
groups. 
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Immunoperoxidase staining. Immunoperoxidase staining was performed to visualize 
microglia activation, as described in (Fritschy and Mohler 1995). Sections were 
incubated overnight at 4°C with primary antibodies diluted in Tris buffer, pH 7.4, 
containing 2% normal goat serum and 0.2% Triton X-100 (Iba-1, 1:3000). Sections were 
washed and incubated for 30 minutes in biotinylated secondary antibodies (1:300; 
Jackson ImmunoResearch, Newmarket, UK), followed by ABC complex for 30 minutes 
(Vectastain Elite kit; Vector Laboratories, Peterborough, UK) and reaction with 
diaminobenzidine tetrahydrochloride (Sigma-Aldrich) for 5–15 minutes in Tris, pH 7.7. 
Finally, sections were washed thoroughly, mounted on gelatin-coated slides, air-dried 
overnight, dehydrated, and coverslipped with Eukitt (Erne Chemie, Dällikon, 
Switzerland). 
Fluorescein-labeled-albumin intravascular filling. Following the perfusion protocol 
described above, a subgroup of animals was perfused with 1% fluorescein-labeled 
albumin (Sigma-Aldrich) and 3% porcine skin gelatin type A (Sigma-Aldrich) in PBS 
(Tsai et al. 2009). The head of the animal was then cooled with ice water to aid 
solidification of the gelatin. For details regarding the gel composition and protocol, see 
Tsai et al. (Tsai et al. 2009). The brain was extracted from the skull and stored for 
cryoprotection in 30% sucrose until it sank. Then, 60-µm-thick frozen sections were cut 
on a sliding microtome (HM 440E; Microm, Walldorf, Germany). Selected sections were 
washed 3 × 5 minutes in 0.1 M PB and incubated for 5 minutes in 0.4 × 10-4% DAPI 
(4',6-diamidino-2-phenylindole dihydrochloride; Sigma-Aldrich) in dH2O to stain the cell 
nuclei for later anatomical orientation. Following another series of three rinses in 0.1 M 
PB, the sections were mounted on glass slides and coverslipped with polyvinyl alcohol 
(Mowiol 4-88; Hoechst, Frankfurt, Germany) containing 4% 1,4-diazabicyclooctane 
(Merck, Darmstadt, Germany) to preserve the fluorescence of the FITC-labeled gelatin 
and the DAPI-labeled cell nuclei. Double-channel (FITC and DAPI) images of the whole 
rat brain sections were taken with a fluorescence microscope (AxioImager.Z1, 5× 
objective; Carl Zeiss, Göttingen, Germany) equipped with a monochrome CCD camera 
(AxioCam HRm, controlled by AxioVision 4.8; Carl Zeiss). 
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RNA isolation, reverse transcription, and quantitative PCR 
Total RNA was isolated from somatosensory cortices of 20- and 40-week-old rats 
using TRIzol® Reagent (Invitrogen, Carlsbad, CA, USA). Reverse transcription was 
performed using Ready-To-Go You-Prime First-Strand Beads (Amersham, 
Buckinghamshire, UK). 
 Quantitative PCR was performed in a Stratagene Mx 3000 P™ machine 
(Stratagene, La Jolla, CA, USA) using the Stratagene MxPro sequence detection 
system and software. SYBR green reagents were used as supplied in the SYBR® 
Green JumpStart™ Taq Ready Mix™ (Sigma, St. Louis, MO, USA). Expression was 
calculated using the ∆∆CT method. Primers were: superoxide dismutase 1 (SOD1): 
forward: 5’-GTG TGC GTG CTG AAG GGC GA-3’, reverse: 5’-CGT GGA CCA CCA 
TAG TAC GGC CA-3’; superoxide dismutase 2 (SOD2): forward: 5’-TCG TGG GCG 
CCT CAG CAA TG-3’, reverse: 5’-AAC ATC TCC CTT GGC CAG CGC-3’; superoxide 
dismutase 3 (SOD3): forward: 5’-TGG GAG AGC TTG TCA GGT GTG GAA C-3’, 
reverse: 5’-CGG CCC AAG ATC GAG TGC GG-3’; endothelial nitric oxide synthase 
(eNOS): forward: 5’-GGC ACC TAC CAG CTC CGG GA-3’, reverse: 5’-GGG GTC AGG 
CTG GTA GCG GA-3’; p47/phox: forward: 5’-ATG ACC GTG GCG ACG GGA GA-3’, 
reverse: 5’-TTG CGG ATG GTC GAC CTG CG-3’; catalase (cat): forward: 5’-ACC GGA 
GGC GGG AAC CCA AT-3’, reverse: 5’-GGC GGC CCT GGA GCA TCT TG-3’; 
GAPDH: forward: 5’-TGC CAA GTA TGA TGA CAT CAA GAA G-3’, reverse 5’-AGC 
CCA GGA TGC CCT TTA GT-3’. Relative gene expression was normalized to GAPDH. 
PCR conditions were: 95°C for 10 minutes, followed by 40 cycles of 95°C for 30 
seconds, 60°C for 1 minute, and 72°C for 1 minute, followed by one cycle of 95°C for 1 
minute, 55°C for 30 seconds, and 95°C for 30 second s. 
Data analysis 
Image analysis was performed using custom-written Matlab routines and the 
software package PMOD (Mikolajczyk et al. 1998a). 
Optical imaging. Data were analyzed as recently reported by our group (Calcinaghi 
et al. 2011). The analysis of the multiwavelength spectroscopy followed the protocol of 
Dunn and colleagues (Dunn et al. 2005). Baseline values for total hemoglobin 
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concentrations were set to 100 µM with 70% oxygen saturation, which implies HbO0 70C =
µM and HbR0 30C = µM. To quantify CBF, speckle images were processed as described 
recently (Zakharov et al. 2009) using 5x5 spatial and 25 temporal binning. Circular 
regions of interest (0.5 mm2) were drawn manually over the area of maximal stimulation-
induced signal increase to extract the signal time courses. 10 trials carried out within 12 
minutes in each animal were averaged. All data represent the mean ± standard error of 
the mean used for each experimental condition. Maximal amplitude, area under the 
curve (AUC) and the full width at 25% of the maximum were determined for instrinsic 
optical imaging data. 
Two-photon laser scanning microscopy. Line scan data were analyzed using the 
Radon transform approach as described in Drew et al.(Drew et al. 2010a). 
Histological image acquisition and processing. Digital images of cresyl violet staining 
were taken and analysis was performed with MCID™ software (InterFocus Imaging Ltd, 
Cambridge, UK). Immunoperoxidase staining analysis was performed using bright-field 
microscopy (Zeiss AxioScope) and images acquired with an 8-bit digital color camera 
(Zeiss AxioCam) controlled by AxioVision 4.5 (Zeiss). 
Analysis of vascular density. Image processing was performed with Matlab 
(Mathworks, Natick, MA, USA). The FITC images were filtered, thresholded, and eroded 
to yield single-pixel-wide traces of the vessels. Layer-specific ROIs of the 
somatosensory cortex were defined manually on the DAPI images and transferred to 
the respective vessel trace from the same location. The length density, mean vessel 
caliber, and volume fraction were then computed stereologically for each cortical layer 
and the white matter (for more details see Weber et al. (2008)). 
Statistics. Differences between hemodynamic responses between different groups 
were statistically analyzed using the Mann-Whitney U test. Data are presented as mean 
± sem.   
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Results 
Mean arterial blood pressure, heart rate and body weight in SHRs and CTRLs 
During the in vivo multimodal imaging experiments, mean arterial blood pressure 
(MAP; mmHg) and heart rate (HR; beats/min) of animals were continuously monitored 
via a catheter inserted into the femoral artery (Fig. 2). SHR start to develop aHT 
between 5 and 10 weeks of age (Okamoto and Aoki 1963). Fig. 2A shows that MAP is 
significantly higher in SHR than in CTRL in all age groups (Box plot of MAP values, 
Mann-Whitney U-test, **p<0.005) and that HT is manifest in SHRs already at 10 weeks 
of age. In contrast to that, HR is significantly higher in SHR than in CTRL only at 40 
weeks of age (Fig. 2B; Box Plot of HR data, Mann-Whitney U-test, **p<0.005; data not 
available for animals in the 10 weeks group). Additionally, all animals were weighted 
before anesthesia was induced. SHR aged 20 and 40 weeks have a smaller body 
weight than CTRL. No body weight difference was observed in the 10 weeks group (Fig. 
2C; Box plot of weight data, Mann-Whitney U-test, **p<0.005). 
 
Paper 2 Figure 2. Mean Arterial Blood Pressure, Heart rate and Body Weight for CTRL and SHR at 10-, 20-, 40 
weeks. 
A, Box plot of mean arterial blood pressure values (MAP) for CTRL (10, 20 and 40 weeks, N=7, 13, 14, respectively) 
and SHR (10, 20 and 40 weeks, N=5, 9, 14, respectively). B, Box plot of heart rate values for CTRL (20 and 40 
weeks, N=5, 8) and SHR (20 and 40 weeks, N=8, 7). C, Box plot of body weight values at the time of the experiment 
for CTRL (10, 20 and 40 weeks, N=8, 14, 15) and SHR (N=6, 9, 13). Stars indicate significance level p<0.005 (Mann-
Whitney U-test). 
 
Hemodynamic responses are impaired in SHRs in the 20 and 40 weeks groups 
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Hemodynamic responses were evoked in the somatosensory cortex by single 
whisker stimulation and imaged using multiwavelength spectroscopy combined with 
laser speckle imaging (Fig. 1). Rats of 10, 20, and 40 weeks of age were imaged 
(CTRL: n=5, 8, 11; SHR: n=5, 7, 12, respectively) and relative changes in total 
hemoglobin or cerebral blood volume (CBV) and CBF were measured. 
 
Paper 2 Figure 3. Impairment of the hemodynamic response increases with duration of aHTN. 
CBV (A) and CBF (B) relative signal changes for CTRLs (black) and SHRs (red). Rats were imaged at 10, 20, and 40 
weeks of age (CTRL: n=5, 8, 11; SHR: n=5, 7, 12, respectively). Area under the curve (AUC), peak signal, and time 
span of CBV (C) and CBF (D) (mean ± s.e.m.; Mann-Whitney U test, * p<0.05, ** p<0.005). 
 
Fig. 3 shows that in the CTRL group, both CBV (panel A) and CBF (panel B) evoked 
signals increased with age. The area under the curve (AUC) and peak response 
exhibited a significant increase from 10 to 20 weeks and remained high in the 40 weeks 
group. In contrast, the time span of the responses was unaltered at 10, 20 and 40 
weeks (Fig. 3C and D). When comparing the 10-week CTRL group with the respective 
age-matched SHR group, we observed very similar hemodynamic responses (peak 
value and AUC) despite the difference in MAP (Fig. 2A). However, as the SHRs aged, 
the evoked responses remained stable until 40 weeks, not displaying any significant 
changes in time span, amplitude, or AUC. Finally, the time span of evoked responses 
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was always slightly but significantly longer in the CTRL group than in the SHR group, 
already apparent at 10 weeks of age. 
10-week treatment with LOS or VER does not normalize hemodynamic responses 
in SHRs 
Next, we investigated whether antihypertensive treatment would restore NVC in 
SHRs. Two separate groups of SHRs were treated, one with the angiotensin II receptor 
1 blocker losartan, the other with the calcium channel blocker verapamil from weeks 30 
to 40 and imaged at 40 weeks of age. The drugs were administered in the drinking 
water at 30 and 80 mg/kg/day, respectively. The MAP of SHRs treated with LOS was 
significantly lowered compared to the MAP of untreated SHRs and reached the level of 
the CTRL group at the time of imaging, indicating that the LOS treatment normalized 
blood pressure values. In the VER treated group, the MAP was significantly lowered 
compared to the SHR group, but did not reach the level observed in CTRL animals (Fig. 
5.E). Treatment with either LOS or VER did not alter body weight nor heart rate in 
comparison to untreated SHRs (Fig. 4). 
Despite a reduction in MAP, the stimulation-evoked hemodynamic responses of 
the LOS and VER groups were not significantly different from those observed in 
untreated SHRs (Fig. 5A and B). None of the parameters used to characterize the 
responses, i.e. AUC, peak response, and time span, was found to be significantly 
different when compared to untreated SHRs (Fig. 5C and D). 
Interestingly, for both CBV and CBF, the peak hemodynamic response and the 
MAP correlated significantly in SHRs (treated and untreated); this correlation was 
absent in CTRL animals (Fig. 5F). Although neither of the treatments affected the 
evoked responses, both treatments did push the animals closer to the region 
corresponding to CTRL animals in these MAP versus peak hemodynamic response 
graphs, with LOS being more effective than VER in line with the reduction in MAP (Fig. 
5E and F). 
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Paper 2 Figure 4. SHR untreated and treated have significant different Heart Rate and Body Weight in 
comparison to CTRL. 
A. Box plot of heart rate (HR; beats/min) in the 40 weeks CTRL group (N=8), in the 40 weeks SHR group (N=7) and 
in both 40 weeks SHR groups treated with Losartan (LOS; N=9) or Verapamil (VER; N=8). Stars indicate significance 
with p-values * p<0.05, ** p<0.005 or *** p<0.0005 (Mann-Whitney U-test). B. Same as in A, but for body weights (g). 
N=13, 13, 10 and 10, respectively. 
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Paper 2 Figure 5. Antihypertensive treatment does not recover hemodynamic response. 
Average evoked CBV (A) and CBF (B) responses in the 40-week-old animals (mean ± s.e.m.): CTRL group (n=11), 
SHR group (n=12), losartan treated group (LOS; n=9), and verapamil treated group (VER; n=8). (C), Area under the 
curve (AUC), peak signal, and time span corresponding to CBV traces in panel A (Mann-Whitney U test, * p<0.05, ** 
p<0.005). (D), Same as in panel C for CBF. (E), Box plot of MAP values for 40-week-old rats (CTRL: n=14, SHR: 
n=14, LOS: n=10, VER: n=9, Mann-Whitney U test, * p<0.05, ** p<0.005). (F), Correlation between peak CBF and 
MAP (top; pink line, R=0.451, p<0.05) and peak CBV and MAP (bottom; pink line, R=0.382, p<0.05) in all 
hypertensive groups (SHR, LOS, and VER). In both cases, no significant correlation was observed to MAP for the 
CTRL group (black lines). 
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Capillary red blood cell velocity correlates with the duration of aHTN 
In order to assess the impact of aHTN and of the LOS and VER treatments on 
baseline microcirculation, we quantified capillary red blood cell (RBC) velocity in all 
groups aged 40 weeks. Two-photon in vivo imaging experiments were conducted and 
RBC velocity was measured in resting conditions from selected straight capillaries in 
layers 2/3 of the somatosensory cortex using the line scan technique (Kleinfeld et al. 
1998) (Fig. 6A). The two-photon experiments were conducted on the same animals 
used for the intrinsic optical imaging experiments and the capillaries were chosen in the 
same barrel cortex area as previously imaged. Fig. 6 shows that RBC velocity in SHRs 
measured during resting conditions was significantly higher than in CTRL animals. 
Treatment with LOS reduced RBC velocity back to CTRL values, whereas treatment 
with VER reduced RBC velocity without reaching statistical significance (Fig. 6B). 
 
Paper 2 Figure 6.  Baseline capillary flow is increased in SHRs. 
(A), Line scans were repeatedly acquired along a capillary segment (magenta line; right panel; scale bar 20 µm) while 
the plasma was loaded with a fluorescent dye, yielding stripes when individual RBCs passed through the capillary 
(left panel; vertical scale bar 100 ms; horizontal scale bar 10 µm). (B), RBC baseline velocity (mean ± sem) for CTRL 
(n=17), SHR (n=12), LOS (n=27), and VER (n=24) (Mann-Whitney U test, ** p<0.005). 
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SHRs exhibit brain atrophy but no changes in microvascular density or vessel 
diameter 
Cerebral atrophy was evaluated in all 40 weeks groups. Compared with CTRL 
animals, SHRs exhibited larger lateral ventricles and a thinner cortex in the occipital 
region (Nissl stained sections; Fig. 8A and B). Both are signs of progressive cerebral 
atrophy (Amenta et al. 2003). 
Detailed analysis of the microvascular network such as volume fraction, length 
density, and vessel diameters revealed no differences between the subgroups at 40 
weeks. In addition, they did not differ from age-matched CTRL animals (Fig. 8C and D). 
No inflammatory reactions observed in the brains of CTRLs, SHRs, and treated 
animals 
Microglial cells are responsive defense cells (Graeber 2010) and can sense 
pathological changes in the central nervous system, exhibiting morphological 
adjustments from a resting ‘ramified’ to an activated state (i.e. still ramified but with 
thicker cell processes) (Graeber 2010). The ionized calcium-binding adaptor molecule 1 
(Iba1) is a macrophage/microglia-specific calcium-binding protein. It has been shown to 
be upregulated during an inflammation process because it is involved in the activation 
pathway (Imai and Kohsaka 2002). In all four groups of 40 weeks of age (CTRL, SHR, 
LOS, and VER), tipical Iba1 staining was observed and no morphological changes 
triggered by inflammation in microglia were detected (Fig. 8A) 
Expression analyses of brain lysates reveal increased levels of eNOS and 
catalase in hypertensive rats 
Expression analyses of brain lysates detected a blood pressure-dependent increase 
in endothelial nitric oxide synthase (eNOS) expression in 20-week-old rats (Fig. 8E), 
indicating an impairment of endothelial homeostasis. Expression levels did not rise 
further in older hypertensive animals. Moreover, we observed an age- and blood 
pressure-dependent increase in cerebral catalase expression, suggestive of enhanced 
levels of oxidative stress upon both aging and sustained hypertension (Fig. 8F). A trend 
towards a blood pressure-dependent increase in ncf1 (active subunit of NADPH 
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oxidase) from 1.08 ± 0.21 to 1.43 ± 0.24 (40 weeks CTRL vs. 40 weeks SHR; n=5, 
p=0.31, Fig. 7A) may contribute to increased generation of reactive oxygen species 
(ROS) in sustained hypertension. 
 
Paper 2 Figure 7. Expression analyses of brain lysates for CTRL and SHR. 
Relative expression histograms of ncf1 (A), SOD1 (B), SOD2 (C), SOD3 (D). Mean ± s.e.m. 
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Paper 2 Figure 8. Structural and biochemical analyses reveal brain atrophy in 40-week-old SHRs 
without active inflammatory reactions and increased anti-oxidant defense. 
(A), Representative example of Iba1 staining (upper panel) and Nissl staining (lower panel) from CTRLs 
and SHRs. 4 brains from every group at 40 weeks age (CTRL, SHR, LOS, VER) were stained for Iba1. 
(B), Box plot of lateral ventricle volumes (mm3, upper panel) and occipital cortex thickness (mm, lower 
panel) measured from Nissl stained sections of 40-week-old rats: CTRL (N=5), SHR (N=4). LOS (N=4) 
and VER (N=5) with the same color code as in Fig. 3. Statistical analysis: asterisks indicate significant 
difference according to Mann-Whitney U test, * p<0.05. Microvascular structure analysis was performed 
from layer 1 to 6 of the barrel cortex: capillary length density (C) and diameter (D) are reported as mean ± 
sem (CTRL n=3, SHR n=5). Expression analyses derived from lysates of the somatosensory cortices of 
20- and 40-week-old rats were assessed by real-time PCR: endothelial nitric oxide synthase (E) and
catalase (F) (Mean ± sem, Mann-Whitney U test, * p<0.05). 
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Discussion 
aHTN constitutes a major risk factor for transient ischemic attacks and stroke that 
represent a major cause of morbidity in Western countries. Several studies have 
investigated the role of aHTN in the pathogenesis of stroke (Sacco 2001) and assessed 
the benefit of lowering elevated blood pressure for stroke prevention. Less is known 
about the impact of aHTN on physiological CBF-related processes such as NVC. 
The present work reports five major findings: (1) CBF alterations occurred only 
after a period of sustained hypertension: 20- and 40- but not 10-week-old SHRs showed 
reduced hemodynamic responses to somatosensory stimulation despite increased MAP 
values already being present in animals of 10 weeks of age; (2) baseline capillary blood 
flow was increased in 40-week-old SHRs compared to age-matched CTRLs; (3) 
antihypertensive treatment recovered baseline capillary RBC velocity but did not affect 
evoked hemodynamic responses; (4) the functional changes were not accompanied by 
structural alterations of the cerebral microvascular network; and (5) sustained 
hypertension increased oxidative stress and impaired endothelial homeostasis. 
A short-term increase in blood pressure is not sufficient to impair NVC 
Our results indicate that aHTN alone does not explain the impairment of the 
neurovascular response. Although increased MAP was already present in 10-week-old 
SHRs (Fig. 2A), the cerebrovascular dysfunction only became evident at the age of 20 
weeks and later (Fig. 3). These results support the notion that the increase in blood 
pressure in the early phase of aHTN may be compensated for by the brain through 
autoregulative processes (Claassen et al. 2008) and is not sufficient to lead to the 
observed functional disturbances in CBF responses. Only at a later stage did we detect 
functional impairment. This finding is in agreement with the work of Capone et al.(2010) 
who demonstrated that acute or chronic non-pressor doses of angiotensin II injected 
into mice induce cerebrovascular dysfunction and increase levels of ROS. Similar to our 
findings, they reported a >40% attenuation of the blood flow response to whisker 
stimulation. Biochemical and structural changes triggered by the chronically increased 
arterial blood pressure may induce a dysfunction in NVC. Higher blood velocity 
associated with aHTN leads to increased shear stress on the blood vessel wall, which 
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has been reported to result in the remodeling of cellular and extracellular components in 
the vessel wall (Baumbach and Heistad 1991; Baumbach et al. 2003). 
Apart from inducing structural changes, aHTN alters molecular mechanisms 
critical for functional integrity at both the neural and vascular level. aHTN is known to 
favor an imbalance in antioxidant defense systems as well as a disruption of endothelial 
homeostasis (Chrissobolis and Faraci 2008; Girouard et al. 2007). In a recent paper, 
Capone and colleagues (2012) demostrated that ROS production in the subfornical 
organ is involved in the NVC impairment observed in aHTN. Similar events may be 
reflected in our expression analyses of cerebral lysates in which we observed increased 
expression levels of the cytosolic active subunit of NADPH oxidase, an important source 
of ROS in endothelial cells. Increased levels of catalase, an enzyme scavenging free 
radicals, suggest a blood pressure- and age-dependent enhancement of this 
antioxidative defense mechanism. Therefore, increased generation of ROS upon aging 
and sustained hypertension may exceed the cerebral antioxidant defense capacity, and 
thereby contribute to cerebral endothelial dysfunction. 
A key mechanism by which intact endothelial cells communicate with the underlying 
vascular smooth muscle cells constitutes eNOS-derived nitric oxide (NO) (Faraci 2006; 
Toda et al. 2009). Endothelial (and neuronal) cell-mediated NO-dependent vascular 
relaxation of cerebral arteries and arterioles is known to contribute to increased CBF. 
We found increased levels of eNOS in 20-week-old hypertensive animals; this may 
reflect a compensatory mechanism in response to reduced CBF. Our finding is in 
accordance with earlier reports describing an upregulation of cerebral eNOS in SHRs 
(Hojna et al. 2007). A similar compensatory increase in eNOS has been described in 
rats upon aging. Van der Loo et al. found an increase in O2–, trapping of vasorelaxant 
NO, and subsequent peroxynitrite formation, followed by nitration and inhibition of 
manganese superoxide dismutase (van der Loo et al. 2009). 
Taken together, these findings may support the notion that insufficient compensation 
for increased cerebral levels of ROS and impaired endothelial homeostasis contribute to 
impaired NVC. 
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Capillary RBC velocity is increased in hypertensive animals 
In addition to the spectroscopic assessment of the hemodynamic response, we 
determined RBC velocity in single capillaries in the somatosensory cortex using two-
photon microscopy. We observed a marked increase in baseline RBC velocity in SHRs 
(40 weeks) compared to normotensive control animals. Our finding is in contrast to the 
findings of other studies showing maintained (Jennings et al. 2005; Wei et al. 1992) or 
decreased CBF (Beason-Held et al. 2007; Fujishima et al. 1995). However, our study is 
the first one to selectively investigate the relationship between blood pressure and CBF 
at the capillary level using two-photon microscopy. The observed velocity increase was 
less pronounced in animals on antihypertensive therapy. The linear correlation between 
MAP and RBC velocity suggests a direct relationship between increased arteriovenous 
pressure gradient and blood flow velocity. For such a direct relationship to be true, two 
prerequisites must be fulfilled: (1) impaired cerebral autoregulation and (2) unaltered 
microvascular density. Both of these prerequisites are discussed in detail below. 
Impaired cerebral autoregulation 
Cerebral autoregulation maintains a constant perfusion of brain parenchyma within a 
certain blood pressure range. Intact cerebral autoregulation depends on various 
mechanisms such as myogenic, neurogenic/sympathetic, and endothelial components 
(Ohta et al. 1991). In sustained aHTN cerebral autoregulation is altered, mainly due to 
vascular hypertrophy (Paulson et al. 1990). The reduced hemodynamic response upon 
activation observed in 20- and 40-week-old SHRs also points to an impaired capacity of 
precapillary vessels to dilate, as otherwise the stimulation-induced increase in blood 
flow would be comparable in normotensive and hypertensive animals. 
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Unchanged microvascular density and diameter 
We were unable to detect changes in vascular density and diameter in the 
somatosensory cortex – even after sustained hypertension. In accordance, other groups 
have not found consistent differences between SHRs and CTRLs in the cerebral 
capillary network (Lin et al. 1990) and in arterial luminal diameter (Struijker Boudier et 
al. 1992). However, this subject requires further study, as diameter changes have been 
described (Baumbach and Heistad 1988). We are aware that the absence of differences 
between SHRs and CTRLs in our histological samples does not exclude them. Our 
histological measurements incompletely reflect the physiological in vivo situation, mainly 
due to a lack of vascular tone and intraluminal pressure. In addition, our histological 
approach has a spatial resolution of 0.7 µm (Weber et al. 2008) and as a consequence 
small differences might remain undetected. 
Antihypertensive treatment reduces baseline CBF but does not normalize 
functional hyperemia in hypertensive animals 
Ten weeks of treatment with the angiotensin II type 1 receptor antagonist losartan or 
with the calcium channel blocker verapamil were not effective in normalizing 
hemodynamic responses towards control levels (Fig. 5). Notably, MAP was successfully 
reduced with both therapeutic regimens. Thus, it appears that lowering blood pressure 
by a 10-week long pharmacological mono-treatment is not sufficient to affect functional 
hemodynamic signals and to compensate for all the involved pathways such as 
increased oxidative stress, endothelial imbalance, and brain atrophy. In contrast, we 
found a significant reduction of the elevated baseline capillary blood flow upon 
treatment with losartan (Fig. 6B). From a fluid dynamics perspective, blood flow velocity 
directly depends on the resistance and the pressure gradient between two 
compartments, which are both increased in hypertension (O'Rourke and Hashimoto 
2007; Ritz et al. 2009) and – according to our data – brought back to a normal level by 
antihypertensive treatment. 
 On the other hand, regeneration of the impaired CBF response upon whisker 
stimulation was not accomplished with the applied treatment. However, a non-significant 
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increase towards the control situation was observed. Fig. 5F illustrates that the 
measurements obtained in treated animals were shifted towards the left and upwards. 
There was a change of the hemodynamic response in these animals towards higher 
hemodynamic signals at lower MAP values. The exact reasons for the incomplete 
recovery after treatment remain unclear. Insufficient treatment duration could be an 
important factor. Furthermore, a single pharmacological target might not be sufficient. 
Indeed, Dupuis and colleagues recently reported that telmisartan – like losartan, an 
angiotensin II type 1 receptor antagonist – does not have a significant impact on mean 
cerebral arteriolar pressure in SHRs (Dupuis et al. 2010). 
Sabbatini et al. (Sabbatini et al. 2001) treated SHRs for 12 weeks with different 
antihypertensive drugs: dihydropyridine-type calcium channel blockers (lercanidipine, 
manidipine, and nimodipine) and hydralazine. The observed loss of frontal, occipital, 
and hippocampal neurons was partially prohibited by the treatments, with a better 
performance of hydralazine, although the drugs showed a similar effect on blood 
pressure. This suggests a neuroprotective effect of hydralazine in hypertensive 
subjects. 
In general, the wide spectrum of different results reported reflects the complex 
nature of cerebrovascular regulation in the pathophysiology of essential aHTN and 
underlines the need for further in vivo research using multimodal imaging technology. 
Limitations 
The use of older animals may allow the effects of sustained aHTN and aging on CBF 
to be specifically addressed. For technical reasons, our two-photon imaging of capillary 
RBC velocity was limited to 40-week-old animals and only included resting state 
measurements. Furthermore, the applied antihypertensive treatment protocol could be 
extended with respect to choice of drugs, dosage, and treatment period. 
Conclusions 
To the best of our knowledge, this is the first study to investigate the effects of 
sustained aHTN on cerebral perfusion in SHRs. With increasing duration of aHTN, we 
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found an increased impairment of the hemodynamic response following sensory 
stimulation and an elevated baseline capillary RBC velocity. Mono-antihypertensive 
treatment either with LOS or with VER reduced blood pressure within 10 weeks but was 
insufficient to normalize the impaired hemodynamic response, indicating the need for 
alternative or additional treatment strategies to address the cerebrovascular functional 
impairment in sustained hypertension. Additional research is required to further 
elucidate possible interactions of sustained aHTN and aging. This will be of particular 
interest for therapeutic efforts aimed at inhibiting the progression of neurodegenerative 
diseases, such as Alzheimer’s disease or vascular dementia, where the 
pathophysiology involves impaired blood supply (Iadecola and Davisson 2008). 
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 Chapter 4. Implications and future directions 
The aim of this thesis was to contribute to a better understanding of the important 
aspects of neurovascular coupling. First, we investigated whether mGluR5 activation is 
the main trigger in the initiation of hemodynamic responses in NVC and whether it is 
directly involved in CBF regulation in the rat somatosensory cortex upon whisker 
stimulation. Second, we studied how hemodynamic responses are affected by arterial 
hypertension in SHR and aged-matched control rats. We also studied whether the 
impairment in NVC with hypertension is reversed by antihypertensive treatment. 
In the following section, I would like to focus on some important implications of our 
results, highlight the relevance of our data and identify potential approaches for use in 
answering remaining research questions.  
Open questions about the role of astrocytes in functional hyperemia 
in vivo  
In the paper, “Metabotropic glutamate receptor mGluR5 is not involved in the early 
hemodynamic response,” it is shown that mGluR5 blockade does not affect the 
hemodynamic response in vivo upon whisker stimulation. Our data challenge a model in 
which astrocytes are the main initiators and principal mediators of functional hyperemia 
in vivo. Some important and as yet unanswered questions will be discussed below. 
A) What is the temporal scale of astrocytic and neuronal signals in the 
functional hyperemia response? 
According to work published to date, the time scales of stimulus-evoked calcium 
changes in astrocytes and of functional hyperemia do not completely match in vivo. In 
various brain areas in several species (mouse somatosensory cortex, ferret visual 
cortex, mouse olfactory glomeruli) the onset of astrocytic calcium changes has been 
described to be in the range of 1-6 seconds (Petzold et al. 2008; Schummers et al. 
2008; Takano et al. 2006; Wang et al. 2006), whereas the hyperemic response typically 
starts about 0.5-1 second after the stimulus onset (Devor et al. 2008; Tian et al. 2010; 
Weber et al. 2004).  
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Furthermore, the activation kinetics of a metabotropic receptor might not be 
compatible with onset of the functional hyperemia response (Perea and Araque 2005). 
How can mGluR5 activation in astrocytes lead to the production of several vasoactive 
molecules in less than 1 second? (Attwell et al. 2010) Here, we try to identify the main 
reasons why in vivo astrocytic calcium waves are detected a few seconds after the 
onset of hyperemia. This delay could possibly be due to some technical issues: (i) the 
calcium signal could be unspecific because synthetic dyes are taken up by all cells, and 
(ii) the indicator molecules could be insufficiently sensitive to detect small changes in 
calcium concentration and may preferentially concentrate in the soma rather than in the 
astrocytic endfeet (Petzold and Murthy 2011). Alternatively, astrocytic calcium waves 
could occur a few seconds after onset of the hyperemic response because they are 
actually involved in the maintenance of the functional hyperemia response, rather than 
in the initiation process. In this regard, neurons that express ionotropic receptors more 
abundantly than astrocytes may be good candidates for initiating the functional 
hyperemia response by means of their fast calcium signal kinetics (Cauli and Hamel 
2010; Petersen et al. 2003). 
B) Are astrocytes activated by glutamate only via mGluR5? 
mGluR5 expression is not restricted to astrocytes. It has been shown that these 
receptors are more abundant in neurons in the mature brain (Barres 2008). Additionally, 
mGluR5 is highly expressed in reactive glia, i.e. in non-physiological states. Another 
important pathway for astrocytic activation by glutamate involves uptake by amino acid 
transporters. Reduced CBF responses were reported after application of TBOA, a 
broad-spectrum glutamate transporter inhibitor, in the olfactory bulb (Gurden et al. 2006; 
Petzold et al. 2008) or in the visual cortex (Schummers et al. 2008). This effect was 
additionally observed after injection of DHK, a selective inhibitor of the astrocytic 
glutamate transporter GLT1 (Petzold et al. 2008). However, transport inhibition may 
increase glutamate concentration in the synaptic space and thereby enhance glutamate 
receptor stimulation. Therefore, it is still unclear how these two described astrocytic 
activation pathways are linked or coordinated during the in vivo functional hyperemic 
response. The cellular mechanisms underlying these effects are yet to be investigated 
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in detail, and further research on these pathways with either selective pharmacological 
tools or novel approaches (see below) is necessary to address specific questions. 
Open questions about hypertension and aging effects on functional 
hyperemia 
In the paper “Multimodal imaging reveals impaired neurovascular coupling after 
chronic hypertension,” a research project was undertaken and reports for the first time 
the effects of hypertension and disease duration on functional hyperemia by means of a 
multimodal imaging approach. In addition to functional evidence of the NVC disruption 
in hypertension, structural analyses were performed on the same rat brains. A better 
understanding of NVC impairment at the NVU level will provide new insights in the 
identification of the pathophysiological processes underlying vascular cognitive 
impairments. However, there remain several questions that need to be specifically 
addressed. 
A) What is the direct effect of oxidative stress on the functional impairment in 
NVC?  
Reactive oxygen species have been identified as key pathogenic effectors of 
cerebrovascular dysfunction during pathological conditions such as hypertension 
(Girouard and Iadecola 2006). In our study, some signs of increased oxidative stress 
have been identified from the rat brain lysates, suggesting that ROS production exceeds 
the antioxidant defense capacity. Increased oxidative stress might be a factor leading to 
the observed dysfunction in NVC and requires further investigation. In angiotensin-
induced hypertension, peroxynitrite inhibitors abolish the angiotensin-induced 
impairment of CBF responses (Girouard et al. 2006). Using our multimodal approach 
applied in SHR and WKR at different ages, it would be useful to better investigate the 
contribution of ROS on NVC impairment and its reversibility upon pharmacological 
treatment (for example with peroxynitrite inhibitors). Such experiments would shed light 
on the responsible mediators of NVC disruption in chronic hypertension and will 
potentially offer new strategies to curtail cerebrovascular oxidative stress with further 
clinical implications. 
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B) When should a successful antihypertensive treatment be started? Is 
treatment with multiple drugs superior to mono-treatment? 
Losartan and verapamil were administered for ten weeks to SHR from age 30 to 40 
weeks. In the treated SHRs the evoked hemodynamic responses did not return to 
control levels whereas RBC velocity responses did. In view of these results, we asked 
ourselves: should this treatment have been started at the onset of hypertension in SHR 
(8-10 weeks) and not when hypertension was already fully established (30th week)? 
Should the treatment period have been longer? Additionally, a mono-therapy was 
employed. Could a multi-treatment approach reverse the functional hyperemia 
impairment observed in 40-week-old SHR? 
General outlook 
NVC process research remains an important area of scientific endeavor with the 
potential to further understanding and improve treatments in clinical populations. Many 
questions remain unanswered but nevertheless important for progress in this field. 
Relevant remaining questions are:  
1) Which are the most important pathways involved in the complex regulation of 
NVC?  
2) Are there specific vasoactive messengers for particular phases of the 
hyperemic response (initiation, maintenance and propagation of 
vasodilation)?  
3) What is the primary target of specific vasoactive molecules (large arterioles, 
precapillary arterioles, capillaries)? 
4) How do different cellular subpopulations - astrocytes, excitatory neurons, 
inhibitory interneurons - contribute to functional hyperemia?  
In attempting to answer these questions, novel techniques and improved 
understanding will be required. Already newly available techniques are lighting the way 
to furthering knowledge in this area. In particular:  
1. Genetic modifications in animals.  
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With our experimental approach as for most pharmacological interventions, 
we were not able to selectively block astrocytic mGluR5. In order to specifically 
distinguish between astrocytic and neuronal receptor contribution to NVC, 
genetically engineered mice could be employed with a receptor knocked out 
(Fiacco et al. 2007) or with an inducible receptor overexpression in a cell specific 
manner. Additionally, to selectively investigate the contribution of glutamate 
transporters in the functional hyperemia process, gene targeted mice lacking 
specific astrocytic glutamate transporters may be used for in vivo experiments. 
2. Technical development/new methodologies. 
Optogenetics is a new approach that allows selective activation of specific cell 
populations by optically activated G-protein coupled receptors (OptoXRs), (Airan 
et al. 2009). This recently introduced technology provides new possibilities for 
studying in vivo intracellular signaling processes with more precise spatio-
temporal control. Specific neurons have been manipulated with 
Channelrhodopsin (ChR2) optogenetic probes, and ChR2 transgenic mice have 
been generated. By means of this technology, results were published recently: 
Lee and colleagues (2010) have demonstrated that cortical pyramidal neurons 
expressing ChR2 evoke changes in fMRI BOLD. Furthermore, Scott and 
colleagues (2012) reported that deep cortical pyramidal neurons expressing 
ChR2 by light activation can evoke changes in optical and CBF signals in the 
somatosensory cortex.  
Following from this work, an interesting idea would be to selectively activate 
by ChR2 astrocytes or specific interneurons and thus observe the selective 
contribution of these specific cells to hemodynamic responses. 
3. NVC in pathologies.  
In the past, most studies of NVC were performed on the healthy humans and 
animals. All the questions we should like to answer ought to be considered with 
regards not only to normal physiological conditions but also to diseases where 
NVC has been shown to be impaired. 
4. Chronic implantation.  
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A possible technical approach may be to study hypertension effects on NVC 
in the same animals examined at different ages. Multiple experiments on the 
same SHR and WKR animals could be performed by employment of an in vivo 
chronic brain imaging approach. Such an approach would allow evaluation of the 
aging process in the same cohort of animals, reducing the individual variability 
and providing important longitudinal data.  
5. Investigation in awake animals. 
The brain imaging experiments described here were performed under 
anesthesia. It has been reported that hemodynamic responses to functional 
stimulation can change according to the anesthetic regime used and between 
anesthetized and awake animals (Drew et al. 2010b). An evaluation of NVC 
mechanisms with a combined approach (anesthetized and awake animals) would 
likely allow identification of artifacts resulting from anesthesia. 
In summary, the results described in this thesis provide new insights into 
understanding the basic principles of NVC in physiological conditions and in the 
presence of hypertension-aging. Our experimental results contribute to better 
interpreting the read-out of neuroimaging studies. With regard to the study on 
hypertension, the inability of the antihypertensive treatment to recover the functional 
hyperemia impairment in aged SHR may be partially responsible for the onset of 
vascular cognitive impairment in elderly patients. This finding has important implications 
for clinical populations and the aged. Further investigation is required to identify 
dysfunction at the NVU level and to unveil the cerebrovascular component of important 
cognitive disorders and degenerative diseases such as Alzheimer’s disease. 
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